CHASE CORP (Form: 10-Q, Received: 07/12/2021 16:52:04)

truefalse0000830524--08-312021Q3YesYes94390829449786P3Yus-gaap:AccruedLiabilitiesCurrentfalse0000830524us-gaap:RetainedEarningsMember2021-05-310000830524us-gaap:AdditionalPaidInCapitalMember2021-05-310000830524us-gaap:AccumulatedTranslationAdjustmentMember2021-05-310000830524us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-05-310000830524us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-05-310000830524us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-05-310000830524us-gaap:RetainedEarningsMember2021-02-280000830524us-gaap:AdditionalPaidInCapitalMember2021-02-280000830524us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-02-2800008305242021-02-280000830524us-gaap:RetainedEarningsMember2020-08-310000830524us-gaap:AdditionalPaidInCapitalMember2020-08-310000830524us-gaap:AccumulatedTranslationAdjustmentMember2020-08-310000830524us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-08-310000830524us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-08-310000830524us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-08-310000830524srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:AccountingStandardsUpdate201802Memberus-gaap:RetainedEarningsMember2020-05-310000830524srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:AccountingStandardsUpdate201802Memberus-gaap:AccumulatedOtherComprehensiveIncomeMember2020-05-310000830524srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2020-05-310000830524srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-05-310000830524us-gaap:RetainedEarningsMember2020-05-310000830524us-gaap:AdditionalPaidInCapitalMember2020-05-310000830524us-gaap:AccumulatedTranslationAdjustmentMember2020-05-310000830524us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-05-310000830524us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-05-310000830524us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-05-310000830524us-gaap:RetainedEarningsMember2020-02-290000830524us-gaap:AdditionalPaidInCapitalMember2020-02-290000830524us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-02-2900008305242020-02-290000830524us-gaap:RetainedEarningsMember2019-08-310000830524us-gaap:AdditionalPaidInCapitalMember2019-08-310000830524us-gaap:AccumulatedTranslationAdjustmentMember2019-08-310000830524us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-08-310000830524us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2019-08-310000830524us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-08-310000830524us-gaap:CommonStockMember2020-03-012020-05-310000830524us-gaap:CommonStockMember2021-05-310000830524us-gaap:CommonStockMember2021-02-280000830524us-gaap:CommonStockMember2020-08-310000830524us-gaap:CommonStockMember2020-05-310000830524us-gaap:CommonStockMember2020-02-290000830524us-gaap:CommonStockMember2019-08-310000830524srt:ManagementMemberccf:LongTermIncentivePlan2020Memberccf:August312022VestingDateMember2019-09-010000830524ccf:NewExecutiveMember2021-02-012021-02-280000830524ccf:RetiredExecutiveOfficerMemberus-gaap:EmployeeStockOptionMember2021-04-012021-04-300000830524ccf:RetiredExecutiveOfficerMemberus-gaap:EmployeeStockOptionMember2021-01-012021-01-310000830524srt:ManagementMemberus-gaap:EmployeeStockOptionMemberccf:LongTermIncentivePlan2021Member2020-09-010000830524ccf:NewExecutiveMemberus-gaap:EmployeeStockOptionMember2021-02-012021-02-280000830524ccf:NewExecutiveMemberccf:TimeBasedRestrictedStockMember2021-02-012021-02-280000830524ccf:NewExecutiveMemberccf:PerformanceAndServiceBasedRestrictedStockMember2021-02-012021-02-280000830524ccf:NonEmployeeMembersOfBoardOfDirectorsMemberus-gaap:RestrictedStockMember2020-12-012020-12-310000830524srt:ManagementMemberccf:TimeBasedRestrictedStockMemberccf:LongTermIncentivePlan2021Memberccf:August312023VestingDateMember2020-09-012020-09-010000830524srt:ManagementMemberccf:PerformanceAndServiceBasedRestrictedStockMemberccf:LongTermIncentivePlan2021Memberccf:August312023VestingDateMember2020-09-012020-09-010000830524srt:ManagementMemberus-gaap:EmployeeStockOptionMemberccf:LongTermIncentivePlan2020Memberccf:August312022VestingDateMember2019-09-012019-09-010000830524srt:ManagementMemberccf:PerformanceAndServiceBasedRestrictedStockMemberccf:LongTermIncentivePlan2020Memberccf:August312022VestingDateMember2019-09-012019-09-010000830524srt:ExecutiveOfficerMemberus-gaap:EmployeeStockOptionMemberccf:EquityRetentionAgreementMemberccf:August312022VestingDateMember2019-09-012019-09-010000830524srt:ExecutiveOfficerMemberccf:TimeBasedRestrictedStockMemberccf:EquityRetentionAgreementMemberccf:August312022VestingDateMember2019-09-012019-09-010000830524ccf:RetiredExecutiveOfficerMemberus-gaap:RestrictedStockMember2021-01-012021-01-310000830524us-gaap:RestrictedStockMemberccf:LongTermIncentivePlan2020Member2020-09-012021-05-310000830524ccf:NonExecutiveOfficerEmployeesMemberus-gaap:RestrictedStockMember2020-09-012020-11-300000830524ccf:NonEmployeeMembersOfBoardOfDirectorsMemberus-gaap:RestrictedStockMember2021-02-012021-02-280000830524ccf:ConsultantMemberus-gaap:RestrictedStockMember2021-02-012021-02-280000830524srt:ManagementMemberccf:LongTermIncentivePlan2020Memberccf:August312022VestingDateMember2019-09-012019-09-010000830524us-gaap:CorporateNonSegmentMember2020-05-012020-05-3100008305242020-05-012020-05-310000830524srt:NorthAmericaMemberccf:IndustrialTapesMember2021-03-012021-05-310000830524srt:NorthAmericaMemberccf:CorrosionProtectionAndWaterproofingMember2021-03-012021-05-310000830524srt:NorthAmericaMemberccf:AdhesivesSealantsAndAdditivesMember2021-03-012021-05-310000830524srt:EuropeMemberccf:IndustrialTapesMember2021-03-012021-05-310000830524srt:EuropeMemberccf:CorrosionProtectionAndWaterproofingMember2021-03-012021-05-310000830524srt:EuropeMemberccf:AdhesivesSealantsAndAdditivesMember2021-03-012021-05-310000830524srt:AsiaMemberccf:IndustrialTapesMember2021-03-012021-05-310000830524srt:AsiaMemberccf:CorrosionProtectionAndWaterproofingMember2021-03-012021-05-310000830524srt:AsiaMemberccf:AdhesivesSealantsAndAdditivesMember2021-03-012021-05-310000830524ccf:OtherCountriesMemberccf:IndustrialTapesMember2021-03-012021-05-310000830524ccf:OtherCountriesMemberccf:CorrosionProtectionAndWaterproofingMember2021-03-012021-05-310000830524ccf:OtherCountriesMemberccf:AdhesivesSealantsAndAdditivesMember2021-03-012021-05-310000830524us-gaap:RoyaltyMember2021-03-012021-05-310000830524us-gaap:ProductMember2021-03-012021-05-310000830524srt:NorthAmericaMember2021-03-012021-05-310000830524srt:EuropeMember2021-03-012021-05-310000830524srt:AsiaMember2021-03-012021-05-310000830524country:US2021-03-012021-05-310000830524country:GB2021-03-012021-05-310000830524ccf:OtherCountriesMember2021-03-012021-05-310000830524ccf:IndustrialTapesMember2021-03-012021-05-310000830524ccf:CorrosionProtectionAndWaterproofingMember2021-03-012021-05-310000830524ccf:AllOtherForeignMember2021-03-012021-05-310000830524ccf:AdhesivesSealantsAndAdditivesMember2021-03-012021-05-310000830524srt:NorthAmericaMemberccf:IndustrialTapesMember2020-09-012021-05-310000830524srt:NorthAmericaMemberccf:CorrosionProtectionAndWaterproofingMember2020-09-012021-05-310000830524srt:NorthAmericaMemberccf:AdhesivesSealantsAndAdditivesMember2020-09-012021-05-310000830524srt:EuropeMemberccf:IndustrialTapesMember2020-09-012021-05-310000830524srt:EuropeMemberccf:CorrosionProtectionAndWaterproofingMember2020-09-012021-05-310000830524srt:EuropeMemberccf:AdhesivesSealantsAndAdditivesMember2020-09-012021-05-310000830524srt:AsiaMemberccf:IndustrialTapesMember2020-09-012021-05-310000830524srt:AsiaMemberccf:CorrosionProtectionAndWaterproofingMember2020-09-012021-05-310000830524srt:AsiaMemberccf:AdhesivesSealantsAndAdditivesMember2020-09-012021-05-310000830524ccf:OtherCountriesMemberccf:IndustrialTapesMember2020-09-012021-05-310000830524ccf:OtherCountriesMemberccf:CorrosionProtectionAndWaterproofingMember2020-09-012021-05-310000830524ccf:OtherCountriesMemberccf:AdhesivesSealantsAndAdditivesMember2020-09-012021-05-310000830524us-gaap:RoyaltyMember2020-09-012021-05-310000830524us-gaap:ProductMember2020-09-012021-05-310000830524srt:NorthAmericaMember2020-09-012021-05-310000830524srt:EuropeMember2020-09-012021-05-310000830524srt:AsiaMember2020-09-012021-05-310000830524country:US2020-09-012021-05-310000830524country:GB2020-09-012021-05-310000830524ccf:OtherCountriesMember2020-09-012021-05-310000830524ccf:IndustrialTapesMember2020-09-012021-05-310000830524ccf:CorrosionProtectionAndWaterproofingMember2020-09-012021-05-310000830524ccf:AllOtherForeignMember2020-09-012021-05-310000830524ccf:AdhesivesSealantsAndAdditivesMember2020-09-012021-05-310000830524srt:NorthAmericaMemberccf:IndustrialTapesMember2020-03-012020-05-310000830524srt:NorthAmericaMemberccf:CorrosionProtectionAndWaterproofingMember2020-03-012020-05-310000830524srt:NorthAmericaMemberccf:AdhesivesSealantsAndAdditivesMember2020-03-012020-05-310000830524srt:EuropeMemberccf:IndustrialTapesMember2020-03-012020-05-310000830524srt:EuropeMemberccf:CorrosionProtectionAndWaterproofingMember2020-03-012020-05-310000830524srt:EuropeMemberccf:AdhesivesSealantsAndAdditivesMember2020-03-012020-05-310000830524srt:AsiaMemberccf:IndustrialTapesMember2020-03-012020-05-310000830524srt:AsiaMemberccf:CorrosionProtectionAndWaterproofingMember2020-03-012020-05-310000830524srt:AsiaMemberccf:AdhesivesSealantsAndAdditivesMember2020-03-012020-05-310000830524ccf:OtherCountriesMemberccf:IndustrialTapesMember2020-03-012020-05-310000830524ccf:OtherCountriesMemberccf:CorrosionProtectionAndWaterproofingMember2020-03-012020-05-310000830524ccf:OtherCountriesMemberccf:AdhesivesSealantsAndAdditivesMember2020-03-012020-05-310000830524us-gaap:RoyaltyMember2020-03-012020-05-310000830524us-gaap:ProductMember2020-03-012020-05-310000830524srt:NorthAmericaMember2020-03-012020-05-310000830524srt:EuropeMember2020-03-012020-05-310000830524srt:AsiaMember2020-03-012020-05-310000830524country:US2020-03-012020-05-310000830524country:GB2020-03-012020-05-310000830524ccf:OtherCountriesMember2020-03-012020-05-310000830524ccf:IndustrialTapesMember2020-03-012020-05-310000830524ccf:CorrosionProtectionAndWaterproofingMember2020-03-012020-05-310000830524ccf:AllOtherForeignMember2020-03-012020-05-310000830524ccf:AdhesivesSealantsAndAdditivesMember2020-03-012020-05-310000830524srt:NorthAmericaMemberccf:IndustrialTapesMember2019-09-012020-05-310000830524srt:NorthAmericaMemberccf:CorrosionProtectionAndWaterproofingMember2019-09-012020-05-310000830524srt:NorthAmericaMemberccf:AdhesivesSealantsAndAdditivesMember2019-09-012020-05-310000830524srt:EuropeMemberccf:IndustrialTapesMember2019-09-012020-05-310000830524srt:EuropeMemberccf:CorrosionProtectionAndWaterproofingMember2019-09-012020-05-310000830524srt:EuropeMemberccf:AdhesivesSealantsAndAdditivesMember2019-09-012020-05-310000830524srt:AsiaMemberccf:IndustrialTapesMember2019-09-012020-05-310000830524srt:AsiaMemberccf:CorrosionProtectionAndWaterproofingMember2019-09-012020-05-310000830524srt:AsiaMemberccf:AdhesivesSealantsAndAdditivesMember2019-09-012020-05-310000830524ccf:OtherCountriesMemberccf:IndustrialTapesMember2019-09-012020-05-310000830524ccf:OtherCountriesMemberccf:CorrosionProtectionAndWaterproofingMember2019-09-012020-05-310000830524ccf:OtherCountriesMemberccf:AdhesivesSealantsAndAdditivesMember2019-09-012020-05-310000830524us-gaap:RoyaltyMember2019-09-012020-05-310000830524us-gaap:ProductMember2019-09-012020-05-310000830524srt:NorthAmericaMember2019-09-012020-05-310000830524srt:EuropeMember2019-09-012020-05-310000830524srt:AsiaMember2019-09-012020-05-310000830524country:US2019-09-012020-05-310000830524country:GB2019-09-012020-05-310000830524ccf:OtherCountriesMember2019-09-012020-05-310000830524ccf:IndustrialTapesMember2019-09-012020-05-310000830524ccf:CorrosionProtectionAndWaterproofingMember2019-09-012020-05-310000830524ccf:AllOtherForeignMember2019-09-012020-05-310000830524ccf:AdhesivesSealantsAndAdditivesMember2019-09-012020-05-310000830524us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2021-05-310000830524us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-05-310000830524us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2020-08-310000830524us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2020-08-310000830524us-gaap:FairValueMeasurementsRecurringMember2020-08-310000830524us-gaap:RetainedEarningsMember2021-03-012021-05-310000830524us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2021-03-012021-05-310000830524us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2020-09-012021-05-310000830524us-gaap:RetainedEarningsMember2020-03-012020-05-310000830524us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2020-03-012020-05-310000830524us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2019-09-012020-05-310000830524ccf:PawtucketRhodeIslandManufacturingFacilityMember2020-04-012020-04-300000830524ccf:AbchimeMember2020-09-012020-09-010000830524us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-09-012021-05-310000830524us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-09-012020-05-310000830524us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-03-012021-05-310000830524us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-09-012021-05-310000830524us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-03-012020-05-310000830524us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-09-012020-05-310000830524us-gaap:AccumulatedTranslationAdjustmentMember2020-09-012021-05-310000830524us-gaap:AccumulatedTranslationAdjustmentMember2019-09-012020-05-310000830524country:US2021-05-310000830524country:GB2021-05-310000830524ccf:AllOtherForeignMember2021-05-310000830524country:US2020-08-310000830524country:GB2020-08-310000830524ccf:AllOtherForeignMember2020-08-310000830524us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-03-012021-05-310000830524us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-03-012021-05-310000830524us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-09-012021-05-310000830524us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-09-012021-05-310000830524us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-03-012020-05-310000830524us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-03-012020-05-310000830524us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2019-09-012020-05-310000830524us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-09-012020-05-310000830524us-gaap:OperatingSegmentsMember2021-03-012021-05-310000830524us-gaap:CorporateNonSegmentMember2021-03-012021-05-310000830524us-gaap:OperatingSegmentsMember2020-09-012021-05-310000830524us-gaap:CorporateNonSegmentMember2020-09-012021-05-310000830524us-gaap:OperatingSegmentsMember2020-03-012020-05-310000830524us-gaap:OperatingSegmentsMember2019-09-012020-05-310000830524ccf:CorrosionProtectionAndWaterproofingMember2020-09-012021-05-310000830524ccf:AdhesivesSealantsAndAdditivesMember2020-09-012021-05-310000830524ccf:EmergingTechnologiesMemberccf:AdhesivesSealantsAndAdditivesMember2020-09-012021-05-310000830524ccf:AbchimeMemberccf:AdhesivesSealantsAndAdditivesMember2020-09-012021-05-310000830524ccf:EmergingTechnologiesMember2020-09-012021-05-310000830524ccf:IndustrialTapesMember2021-05-310000830524ccf:CorrosionProtectionAndWaterproofingMember2021-05-310000830524ccf:AdhesivesSealantsAndAdditivesMember2021-05-310000830524ccf:EmergingTechnologiesMember2021-02-050000830524ccf:IndustrialTapesMember2020-08-310000830524ccf:CorrosionProtectionAndWaterproofingMember2020-08-310000830524ccf:AdhesivesSealantsAndAdditivesMember2020-08-310000830524us-gaap:OtherOperatingIncomeExpenseMember2021-03-012021-05-310000830524us-gaap:OtherOperatingIncomeExpenseMember2020-09-012021-05-310000830524us-gaap:OtherOperatingIncomeExpenseMember2020-03-012020-05-310000830524us-gaap:OtherOperatingIncomeExpenseMember2019-09-012020-05-310000830524us-gaap:TradeNamesMember2021-05-310000830524ccf:PatentsAndAgreementsMember2021-05-310000830524ccf:FormulasAndTechnologyMember2021-05-310000830524ccf:CustomerListsAndRelationshipsMember2021-05-310000830524us-gaap:TradeNamesMember2020-08-310000830524ccf:PatentsAndAgreementsMember2020-08-310000830524ccf:FormulasAndTechnologyMember2020-08-310000830524ccf:CustomerListsAndRelationshipsMember2020-08-310000830524us-gaap:RetainedEarningsMember2020-09-012021-05-310000830524us-gaap:RetainedEarningsMember2019-09-012020-05-310000830524us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2020-03-012020-05-310000830524us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2019-09-012020-05-310000830524us-gaap:CorporateNonSegmentMember2019-09-012020-05-310000830524us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-03-012021-05-310000830524us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-09-012021-05-310000830524us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-03-012020-05-310000830524us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-09-012020-05-310000830524srt:MinimumMemberccf:NewCreditAgreementMemberus-gaap:LondonInterbankOfferedRateLIBORMember2020-09-012021-05-310000830524srt:MaximumMemberccf:NewCreditAgreementMemberus-gaap:LondonInterbankOfferedRateLIBORMember2020-09-012021-05-3100008305242020-05-3100008305242019-08-310000830524ccf:NewarkMember2021-03-012021-05-310000830524ccf:NewarkMemberccf:AdhesivesSealantsAndAdditivesMember2020-12-012021-02-280000830524us-gaap:CorporateNonSegmentMemberccf:GraniteFallsMemberccf:IndustrialTapesMember2020-09-012021-05-310000830524ccf:NewarkMemberccf:AdhesivesSealantsAndAdditivesMember2020-09-012021-05-310000830524ccf:NewarkMember2020-09-012021-05-310000830524ccf:GraniteFallsMember2020-09-012021-05-310000830524ccf:GraniteFallsMember2020-03-012020-08-310000830524us-gaap:CorporateNonSegmentMemberccf:PawtucketRhodeIslandManufacturingFacilityMember2020-03-012020-05-310000830524ccf:PawtucketRhodeIslandManufacturingFacilityMember2020-03-012020-05-310000830524ccf:GraniteFallsMember2019-09-012020-02-290000830524ccf:GraniteFallsMember2019-03-012019-08-310000830524us-gaap:CorporateNonSegmentMemberccf:EngineeringStudiesForFacilityConsolidationAndRationalizationInitiativeMember2019-09-012020-05-310000830524ccf:EngineeringStudiesForFacilityConsolidationAndRationalizationInitiativeMember2019-09-012020-02-290000830524us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2021-05-310000830524us-gaap:FairValueMeasurementsRecurringMember2021-05-310000830524ccf:AbchimeMember2021-05-310000830524us-gaap:CorporateNonSegmentMemberccf:EmergingTechnologiesMember2021-02-012021-02-280000830524us-gaap:CorporateNonSegmentMemberccf:PawtucketRhodeIslandManufacturingFacilityMember2019-09-012020-05-310000830524us-gaap:OperatingSegmentsMember2021-05-310000830524us-gaap:CorporateNonSegmentMember2021-05-310000830524ccf:IndustrialTapesMember2021-05-310000830524ccf:CorrosionProtectionAndWaterproofingMember2021-05-310000830524ccf:AdhesivesSealantsAndAdditivesMember2021-05-310000830524us-gaap:OperatingSegmentsMember2020-08-310000830524us-gaap:CorporateNonSegmentMember2020-08-310000830524ccf:IndustrialTapesMember2020-08-310000830524ccf:CorrosionProtectionAndWaterproofingMember2020-08-310000830524ccf:AdhesivesSealantsAndAdditivesMember2020-08-310000830524us-gaap:AdditionalPaidInCapitalMember2020-03-012020-05-310000830524us-gaap:OperatingSegmentsMemberccf:IndustrialTapesMember2021-03-012021-05-310000830524us-gaap:OperatingSegmentsMemberccf:CorrosionProtectionAndWaterproofingMember2021-03-012021-05-310000830524us-gaap:OperatingSegmentsMemberccf:AdhesivesSealantsAndAdditivesMember2021-03-012021-05-310000830524us-gaap:OperatingSegmentsMemberccf:IndustrialTapesMember2020-09-012021-05-310000830524us-gaap:OperatingSegmentsMemberccf:CorrosionProtectionAndWaterproofingMember2020-09-012021-05-310000830524us-gaap:OperatingSegmentsMemberccf:AdhesivesSealantsAndAdditivesMember2020-09-012021-05-310000830524us-gaap:OperatingSegmentsMemberccf:IndustrialTapesMember2020-03-012020-05-310000830524us-gaap:OperatingSegmentsMemberccf:CorrosionProtectionAndWaterproofingMember2020-03-012020-05-310000830524us-gaap:OperatingSegmentsMemberccf:AdhesivesSealantsAndAdditivesMember2020-03-012020-05-310000830524us-gaap:OperatingSegmentsMemberccf:IndustrialTapesMember2019-09-012020-05-310000830524us-gaap:OperatingSegmentsMemberccf:CorrosionProtectionAndWaterproofingMember2019-09-012020-05-310000830524us-gaap:OperatingSegmentsMemberccf:AdhesivesSealantsAndAdditivesMember2019-09-012020-05-310000830524ccf:EmergingTechnologiesMember2020-12-012021-02-280000830524ccf:AbchimeMember2020-03-012020-05-310000830524ccf:AbchimeMember2019-09-012020-08-310000830524ccf:AbchimeMember2019-09-012020-05-3100008305242020-08-3100008305242021-06-300000830524ccf:NewCreditAgreementMemberus-gaap:LondonInterbankOfferedRateLIBORMember2020-09-012021-05-310000830524us-gaap:AdditionalPaidInCapitalMember2021-03-012021-05-310000830524us-gaap:AdditionalPaidInCapitalMember2020-09-012021-05-310000830524us-gaap:AdditionalPaidInCapitalMember2019-09-012020-05-310000830524us-gaap:CommonStockMember2021-03-012021-05-310000830524us-gaap:CommonStockMember2020-09-012021-05-310000830524us-gaap:CommonStockMember2019-09-012020-05-310000830524srt:ManagementMemberus-gaap:EmployeeStockOptionMemberccf:LongTermIncentivePlan2021Member2020-09-012020-09-010000830524ccf:PawtucketRhodeIslandManufacturingFacilityMember2018-06-252018-06-250000830524ccf:NewCreditAgreementMember2020-09-012021-05-310000830524ccf:Covid19Member2020-03-012020-05-310000830524us-gaap:CorporateNonSegmentMember2020-03-012020-05-310000830524us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-09-012021-05-310000830524us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2019-09-012020-05-3100008305242020-03-012020-05-3100008305242019-09-012020-05-310000830524ccf:NewCreditAgreementMember2016-12-1500008305242021-05-310000830524us-gaap:TradeNamesMember2020-09-012021-05-310000830524ccf:PatentsAndAgreementsMember2020-09-012021-05-310000830524ccf:FormulasAndTechnologyMember2020-09-012021-05-310000830524ccf:CustomerListsAndRelationshipsMember2020-09-012021-05-310000830524us-gaap:TradeNamesMember2019-09-012020-08-310000830524ccf:PatentsAndAgreementsMember2019-09-012020-08-310000830524ccf:FormulasAndTechnologyMember2019-09-012020-08-310000830524ccf:CustomerListsAndRelationshipsMember2019-09-012020-08-310000830524srt:MaximumMemberccf:NewCreditAgreementMember2016-12-152016-12-150000830524srt:MinimumMemberccf:NewCreditAgreementMember2016-12-152016-12-150000830524ccf:NewCreditAgreementMember2021-05-310000830524ccf:EmergingTechnologiesMember2021-02-052021-02-050000830524ccf:AbchimeMember2020-09-010000830524ccf:AbchimeMemberccf:AdhesivesSealantsAndAdditivesMember2021-03-012021-05-310000830524ccf:AbchimeMember2021-03-012021-05-3100008305242021-03-012021-05-310000830524ccf:AbchimeMemberccf:AdhesivesSealantsAndAdditivesMember2020-09-012021-05-310000830524ccf:AbchimeMember2020-09-012021-05-3100008305242020-09-012021-05-310000830524us-gaap:CorporateNonSegmentMemberccf:PawtucketRhodeIslandManufacturingFacilityMember2020-04-012020-04-30iso4217:USDiso4217:EURxbrli:purexbrli:sharesccf:itemiso4217:USDxbrli:sharesccf:segment

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended May 31, 2021

Commission File Number: 1-9852

CHASE CORPORATION

(Exact name of registrant as specified in its charter)


Massachusetts		11-1797126
(State or other jurisdiction of incorporation of organization)		(I.R.S. Employer Identification No.)

295 University Avenue, Westwood, Massachusetts 02090

(Address of Principal Executive Offices) (Zip Code)

(781) 332-0700

(Registrant’s Telephone Number, Including Area Code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Common stock, $.10 par value

Trading Symbol(s)

CCF

Name of each exchange on which registered

NYSE American

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months, and (2) has been subject to such filing requirements for the past 90 days. YES ⌧ NO ◻

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). YES ⌧ NO ◻

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.


Large accelerated filer ◻	Accelerated filer ⌧
Non-accelerated filer ◻	Smaller reporting company ☐
Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻

Indicate by checkmark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES ☐ NO ⌧

The number of shares of Common Stock outstanding as of June 30, 2021 was 9,449,248.

Table of Contents

CHASE CORPORATION

INDEX TO FORM 10-Q

For the Quarter Ended May 31, 2021

Ca
Cautionary Note Concerning Forward-Looking Statements		3

Part I - FINANCIAL INFORMATION

Item 1 – Unaudited Condensed Consolidated Financial Statements

Condensed Consolidated Balance Sheets as of May 31, 2021 (unaudited) and August 31, 2020		4

Condensed Consolidated Statements of Operations for the three and nine months ended May 31, 2021 and 2020 (unaudited)		5

Condensed Consolidated Statements of Comprehensive Income for the three and nine months ended May 31, 2021 and 2020 (unaudited)		6

Condensed Consolidated Statements of Equity for the three and nine months ended May 31, 2021 and 2020 (unaudited)		7

Condensed Consolidated Statements of Cash Flows for the nine months ended May 31, 2021 and 2020 (unaudited)		9

Notes to Unaudited Condensed Consolidated Financial Statements		10

Item 2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations		32

Item 3 – Quantitative and Qualitative Disclosures About Market Risk		44

Item 4 – Controls and Procedures		45

Part II – OTHER INFORMATION

Item 1 – Legal Proceedings		46

Item 1A – Risk Factors		46

Item 6 – Exhibits		46

SIGNATURES		47

Table of Contents

Cautionary Note Concerning Forward-Looking Statements

This Quarterly Report on Form 10-Q contains "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements, including without limitation forward-looking statements made under the caption “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” involve risks and uncertainties. Any statements contained in this Quarterly Report that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements include, without limitation, statements as to Chase Corporation’s future operating results; seasonality expectations; plans for the development, utilization or disposal of manufacturing facilities; future economic conditions; its expectations as to legal proceedings; the effect of its market and product development efforts; expectations relating to the renewal of its credit facility; and expectations or plans relating to the implementation or realization of its strategic goals and future growth, including through potential future acquisitions and divestitures. Forward-looking statements may also include, among other things, statements relating to future sales, earnings, cash flow, results of operations, use of cash and other measures of financial performance, statements relating to future dividend payments, as well as the expected impact of the coronavirus disease 2019 (COVID-19) pandemic on the Company's businesses. Forward-looking statements may be identified through the use of words such as “believes,” “anticipates,” “may,” “should,” “will,” “plans,” “projects,” “expects,” “expectations,” “estimates,” “predicts,” “targets,” “forecasts,” “strategy,” and other words of similar meaning in connection with the discussion of future operating or financial performance. These statements are based on current expectations, estimates and projections about the industries in which the Company operates, and the beliefs and assumptions made by management. Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and changes in circumstances that are difficult to predict. Accordingly, the Company’s actual results may differ materially from those contemplated by the forward-looking statements. Investors, therefore, are cautioned against relying on any of these forward-looking statements. They are neither statements of historical fact nor guarantees or assurances of future performance. Readers should refer to the discussions under “Risk Factors” contained in our Annual Report on Form 10-K for the fiscal year ended August 31, 2020 concerning certain factors that could cause our actual results to differ materially from the results anticipated in such forward-looking statements. These Risk Factors are hereby incorporated by reference into this Quarterly Report.

Table of Contents

Item 1 — Unaudited Condensed Consolidated Financial Statements

CHASE CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

In thousands, except share and per share amounts


	May 31,		August 31,
	2021		2020
ASSETS
Current Assets
Cash and cash equivalents	$	102,947	$	99,068
Accounts receivable, less allowance for doubtful accounts and credit losses of $434 and $438		45,515		36,993
Inventory		38,395		39,058
Prepaid expenses and other current assets		2,616		2,470
Prepaid income taxes		5,018		231
Total current assets		194,491		177,820

Property, plant and equipment, less accumulated depreciation of $52,263 and $52,283		24,685		25,574

Other Assets
Goodwill		98,457		82,402
Intangible assets, less accumulated amortization of $88,593 and $78,351		50,617		41,200
Cash surrender value of life insurance		4,450		4,450
Restricted investments		2,038		1,619
Deferred income taxes		4,856		4,929
Operating lease right-of-use asset (Note 8)		9,787		8,821
Other assets		853		15
Total assets	$	390,234	$	346,830

LIABILITIES AND EQUITY
Current Liabilities
Accounts payable	$	16,419	$	12,525
Accrued payroll and other compensation		6,619		5,751
Accrued expenses		4,159		4,867
Total current liabilities		27,197		23,143

Operating lease long-term liabilities (Note 8)		7,601		6,395
Deferred compensation		2,045		1,629
Accumulated pension obligation		9,992		10,930
Other liabilities		2,939		—
Deferred income taxes		3,327		—
Accrued income taxes		1,847		1,941

Commitments and contingencies (Note 10)

Equity
First Serial Preferred Stock, $1.00 par value: Authorized 100,000 shares; none issued		—		—
Common stock, $.10 par value: Authorized 20,000,000 shares; 9,449,786 shares at May 31, 2021 and 9,439,082 shares at August 31, 2020 issued and outstanding		946		944
Additional paid-in capital		18,596		16,674
Accumulated other comprehensive loss		(9,262)		(13,092)
Retained earnings		325,006		298,266
Total equity		335,286		302,792
Total liabilities and equity	$	390,234	$	346,830

See accompanying notes to the condensed consolidated financial statements

Table of Contents

CHASE CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

In thousands, except share and per share amounts


	Three Months Ended May 31,				Nine Months Ended May 31,
	2021		2020		2021		2020

Revenue
Sales	$	78,822	$	64,157	$	212,533	$	194,540
Royalties and commissions		771		714		2,683		2,715
		79,593		64,871		215,216		197,255
Costs and Expenses
Cost of products and services sold		46,312		39,689		126,832		122,138
Selling, general and administrative expenses		13,969		11,795		38,560		37,025
Research and product development costs		957		958		3,034		3,045
Operations optimization costs (Note 15)		22		268		120		977
Acquisition-related costs (Note 17)		—		20		128		153
Gain on sale of real estate (Note 15)		—		(760)		—		(760)
Loss (gain) on contingent consideration (Note 17)		262		—		995		—

Operating income		18,071		12,901		45,547		34,677

Interest expense		(68)		(67)		(204)		(178)
Other income (expense)		(260)		(307)		(758)		(1,096)

Income before income taxes		17,743		12,527		44,585		33,403

Income taxes (Note 14)		3,454		2,619		10,288		8,254

Net income	$	14,289	$	9,908	$	34,297	$	25,149


Net income available to common shareholders, per common and common equivalent share (Note 4)

Basic	$	1.51	$	1.05	$	3.63	$	2.67

Diluted	$	1.50	$	1.04	$	3.61	$	2.64

Weighted average shares outstanding
Basic		9,386,814		9,363,559		9,381,433		9,357,176
Diluted		9,435,335		9,429,263		9,426,879		9,435,897

Annual cash dividends declared per share					$	0.80	$	0.80

See accompanying notes to the condensed consolidated financial statements

Table of Contents

CHASE CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(UNAUDITED)

In thousands, except share and per share amounts


	Three Months Ended May 31,				Nine Months Ended May 31,
	2021		2020		2021		2020
Net income	$	14,289	$	9,908	$	34,297	$	25,149

Other comprehensive income (loss):
Net unrealized gain on restricted investments, net of tax		68		7		186		5
Change in funded status of pension plans, net of tax		124		185		371		444
Foreign currency translation adjustment		1,386		(1,077)		3,273		318
Total other comprehensive income (loss)		1,578		(885)		3,830		767

Comprehensive income	$	15,867	$	9,023	$	38,127	$	25,916

See accompanying notes to the condensed consolidated financial statements

Table of Contents

CHASE CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF EQUITY

THREE MONTHS ENDED MAY 31, 2021 AND 2020

(UNAUDITED)

In thousands, except share and per share amounts


				Additional		Accumulated Other				Total
	Common Stock			Paid-In		Comprehensive		Retained		Stockholders'
	Shares	Amount		Capital		Income (Loss)		Earnings		Equity
Balance at February 29, 2020	9,448,620	$	945	$	15,882	$	(14,060)	$	279,350	$	282,117
Restricted stock grants, net of forfeitures	(432)		—		—						—
Amortization of restricted stock grants					606						606
Amortization of stock option grants					231						231
Common stock retained to pay statutory minimum withholding taxes on common stock	(5,790)		—		(484)						(484)
Change in funded status of pension plans, net of tax $65							185				185
Foreign currency translation adjustment							(1,077)				(1,077)
Net unrealized gain (loss) on restricted investments, net of tax $4							7				7
Net income									9,908		9,908
Balance at May 31, 2020	9,442,398	$	945	$	16,235	$	(14,945)	$	289,258	$	291,493

Balance at February 28, 2021	9,448,371	$	946	$	17,721	$	(10,840)	$	310,717	$	318,544
Amortization of restricted stock grants					600						600
Amortization of stock option grants					195						195
Exercise of stock options	2,149		—		166						166
Common stock received for payment of stock option exercises	(689)		—		(80)						(80)
Common stock retained to pay statutory minimum withholding taxes on common stock	(45)		—		(6)						(6)
Change in funded status of pension plans, net of tax $41							124				124
Foreign currency translation adjustment							1,386				1,386
Net unrealized gain (loss) on restricted investments, net of tax $24							68				68
Net income									14,289		14,289
Balance at May 31, 2021	9,449,786	$	946	$	18,596	$	(9,262)	$	325,006	$	335,286

See accompanying notes to the condensed consolidated financial statements

Table of Contents

CHASE CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF EQUITY

NINE MONTHS ENDED MAY 31, 2021 AND 2020

(UNAUDITED)

In thousands, except share and per share amounts


				Additional		Accumulated Other				Total
	Common Stock			Paid-In		Comprehensive		Retained		Stockholders'
	Shares	Amount		Capital		Income (Loss)		Earnings		Equity
Balance at August 31, 2019	9,400,748	$	940	$	14,351	$	(14,324)	$	270,260	$	271,227
Restricted stock grants, net of forfeitures	44,879		5		(5)						—
Amortization of restricted stock grants					1,686						1,686
Amortization of stock option grants					687						687
Exercise of stock options	3,618		—		123						123
Common stock received for payment of stock option exercises	(1,057)		—		(123)						(123)
Common stock retained to pay statutory minimum withholding taxes on common stock	(5,790)		—		(484)						(484)
Cash dividend on common stock, $0.80 per share									(7,539)		(7,539)
Change in funded status of pension plans, net of tax $156							444				444
Foreign currency translation adjustment							318				318
Net unrealized gain (loss) on restricted investments, net of tax $3							5				5
Adoption of ASU 2018-02							(1,388)		1,388		—
Net income									25,149		25,149
Balance at May 31, 2020	9,442,398	$	945	$	16,235	$	(14,945)	$	289,258	$	291,493

Balance at August 31, 2020	9,439,082	$	944	$	16,674	$	(13,092)	$	298,266	$	302,792
Restricted stock grants, net of forfeitures	10,693		2		(2)						—
Amortization of restricted stock grants					1,789						1,789
Amortization of stock option grants					420						420
Exercise of stock options	4,681		—		207						207
Common stock received for payment of stock option exercises	(1,075)		—		(121)						(121)
Common stock retained to pay statutory minimum withholding taxes on common stock	(3,595)		—		(371)						(371)
Cash dividend on common stock, $0.80 per share									(7,557)		(7,557)
Change in funded status of pension plans, net of tax $124							371				371
Foreign currency translation adjustment							3,273				3,273
Net unrealized gain (loss) on restricted investments, net of tax $63							186				186
Net income									34,297		34,297
Balance at May 31, 2021	9,449,786	$	946	$	18,596	$	(9,262)	$	325,006	$	335,286

See accompanying notes to the condensed consolidated financial statements

Table of Contents

CHASE CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

In thousands


	Nine Months Ended May 31,
	2021		2020
CASH FLOWS FROM OPERATING ACTIVITIES
Net income	$	34,297	$	25,149
Adjustments to reconcile net income to net cash provided by operating activities
Gain on sale of real estate		—		(760)
Depreciation		2,925		2,989
Amortization		9,566		8,724
Recovery of allowance for doubtful accounts and credit losses		(8)		(307)
Stock-based compensation		2,209		2,373
Realized gain on restricted investments		(54)		(32)
Pension curtailment and settlement loss		—		75
Deferred taxes		—		(15)
Increase (decrease) from changes in assets and liabilities
Accounts receivable		(6,946)		3,656
Inventory		2,062		1,835
Prepaid expenses and other assets		(260)		(154)
Accounts payable		3,049		(183)
Accrued compensation and other expenses		1,044		(1,263)
Accrued income taxes		(4,884)		578
Net cash provided by operating activities		43,000		42,665

CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property, plant and equipment		(1,749)		(1,044)
Payments for acquisitions		(31,238)		—
Proceeds from sale of real estate		—		1,810
Changes in restricted investments		(119)		(115)
Net cash (used in) provided by investing activities		(33,106)		651

CASH FLOWS FROM FINANCING ACTIVITIES
Dividend paid		(7,557)		(7,539)
Proceeds from exercise of common stock options		86		—
Payments of taxes on stock options and restricted stock		(371)		(484)
Net cash used in financing activities		(7,842)		(8,023)

INCREASE IN CASH & CASH EQUIVALENTS		2,052		35,293
Effect of foreign exchange rates on cash		1,827		195
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD		99,068		47,771
CASH AND CASH EQUIVALENTS, END OF PERIOD	$	102,947	$	83,259

Non-cash Investing and Financing Activities
Common stock received for payment of stock option exercises	$	121	$	123
Property, plant and equipment additions included in accounts payable	$	141	$	236

See accompanying notes to the condensed consolidated financial statements

Table of Contents

CHASE CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

In thousands, except share and per share amounts

Note 1 — Basis of Financial Statement Presentation

Description of Business

Chase Corporation (the “Company,” “Chase,” “we,” or “us”), a global specialty chemicals company founded in 1946, is a leading manufacturer of protective materials for high-reliability applications across diverse market sectors. The Company’s strategy is to maximize the performance of its core businesses and brands while seeking future opportunities through strategic acquisitions. Through investments in facilities, systems and organizational consolidation, the Company seeks to improve performance and gain economies of scale.

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with United States of America generally accepted accounting principles (“U.S. GAAP”) for interim financial reporting, and instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Therefore, they do not include all information and footnote disclosures necessary for a complete presentation of Chase Corporation’s financial position, results of operations and cash flows in conformity with generally accepted accounting principles. The year-end condensed balance sheet was derived from audited financial statements but does not include all disclosures required by accounting principles generally accepted in the United States of America. Chase Corporation filed audited consolidated financial statements which included all information and notes necessary for such a complete presentation for the three years ended August 31, 2020 in conjunction with its 2020 Annual Report on Form 10-K. Certain immaterial reclassifications have been made to the prior year amounts to conform to the current year’s presentation.

The results of operations for the interim period ended May 31, 2021 are not necessarily indicative of the results to be expected for any future period or the entire fiscal year. These interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements for the year ended August 31, 2020 which are contained in the Company’s 2020 Annual Report on Form 10-K.

The accompanying unaudited condensed consolidated financial statements contain all adjustments (consisting of normal recurring items) that are, in the opinion of management, necessary for a fair statement of the Company’s financial position as of May 31, 2021, and the results of its operations, comprehensive income, changes in equity and cash flows for the interim periods ended May 31, 2021 and 2020.

The financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. The Company uses the U.S. dollar as the reporting currency for financial reporting. The financial position and results of operations of the Company’s U.K.-based operations are measured using the British pound as the functional currency. The financial position and results of operations of the Company’s operations based in France (including ABchimie acquired September 1, 2020) are measured using the euro as the functional currency. The financial position and results of the Company’s HumiSeal India Private Limited business are measured using the Indian rupee as the functional currency. The functional currency for all Chase Corporation’s other operations is the U.S. dollar. Foreign currency translation gains and losses are determined using current exchange rates for monetary items and historical exchange rates for other balance sheet items and are recorded as a change in other comprehensive income. Transaction gains and losses generated from the remeasurement of assets and liabilities denominated in currencies other than the functional currency of each applicable operation are included in other income (expense) on the condensed consolidated statements of operations, and were ($241) and ($678) for the three- and nine-month periods ended May 31, 2021, respectively, and $155 and ($451) for the three- and nine-month periods ended May 31, 2020, respectively.

Table of Contents

Other Business Developments

During the third quarter of fiscal 2021, Chase announced to the employees at its Woburn, MA location that its adhesives systems operations, part of the Adhesive, Sealants and Additives segment’s electronic and industrial coatings product line, would be consolidating into the Company’s existing O'Hara Township, PA location. This rationalization and consolidation initiative-related announcement aligns with the second quarter announcement of the Company’s plan to move its sealant systems production from Newark, CA to its location in Hickory, NC, described in more detail below. Chase Corporation obtained both the adhesive and sealants systems as part of its fiscal 2017 acquisition of the operations of Resin Designs. No expense was recognized related to this initiative during the third fiscal quarter, with the majority of future costs anticipated to occur in the first half of fiscal 2022.

On February 5, 2021, the Company acquired certain assets of Emerging Technologies, Inc. (“ETi”), a superabsorbent polymers solutions provider, located in Greensboro, NC. The business was acquired for a purchase price of $9,997, comprising $8,997 paid on February 5, 2021 and an accrual of $1,000 to be paid out up to eighteen months after purchase, subsequent to final working capital adjustments, and excluding acquisition-related costs. As part of this transaction, Chase acquired substantially all working capital and fixed assets of the business and entered a multi-year lease at ETi’s existing location. The Company expensed $128 of acquisition-related costs during the three-month period ended February 28, 2021 associated with this acquisition. The purchase was funded with available cash on hand. ETi is a solutions provider and formulator of absorbent polymers for use in the packaging, recreational, consumer, and sanitation markets. The acquisition broadens the Company’s superabsorbent polymers product offerings and formulation capabilities while expanding its market reach. The Company is currently in the process of finalizing purchase accounting, regarding a final allocation of the purchase price to tangible and identifiable intangible assets assumed, and anticipates completion within fiscal 2021. Since the effective date of the acquisition, the financial results of ETi’s acquired operations have been included in the Company’s financial statements within the functional additives product line, contained within the Adhesives, Sealants and Additives operating segment. See Note 17 to the condensed consolidated financial statements for additional information on the acquisition of the assets and operations of ETi.

During the second quarter of fiscal 2021, Chase began moving the sealant systems operations, part of the Adhesive, Sealants and Additives segment’s electronic and industrial coatings product line, from its Newark, CA location to its Hickory, NC facility. This is in line with the Company’s ongoing initiative to consolidate its manufacturing plants and streamline its existing processes. The sealant systems operations and Newark, CA location came to Chase Corporation as part of the fiscal 2017 acquisition of the operations of Resin Designs, and the Company’s lease there terminates in the current fiscal year. The Company recognized $22 and $120 in expense related to the move in the three-month and nine-month periods ended May 31, 2021.

On September 1, 2020 (the first day of fiscal 2021), the Company acquired all the capital stock of ABchimie for €18,654 (approximately $22,241 at the time of the transaction) net of cash acquired, subsequent to final working capital adjustment, excluding acquisition-related costs totaling $274 recognized in fiscal 2020 (with $20 and $153 recognized in the three and nine months ended May 31, 2020, respectively) and with a potential earn out based on performance potentially worth an additional €7,000 (approximately $8,330 at the time of the transaction). ABchimie is a Corbelin, France headquartered solutions provider for the cleaning and protection of electronic assemblies, with ‎further formulation, production, and research and development capabilities‎. The transaction was funded with cash on hand. The financial results of the business were included in the Company's fiscal 2021 financial statements within the Adhesives, Sealants and Additives operating segment in the electronic and industrial coatings product line. The Company is currently in the process of finalizing purchase accounting regarding a final allocation of the purchase price to tangible and identifiable intangible assets assumed, including finalizing the recording of deferred taxes, and anticipates completion within fiscal 2021. See Note 17 to the condensed consolidated financial statements for additional information on the acquisition of ABchimie.

Table of Contents

The Company’s second quarter of fiscal 2020 (prior year) saw the beginning of the global spread of the coronavirus pandemic (COVID-19), which subsequently grew to create significant volatility, uncertainty, and global economic disruption. While the Company remains profitable with sufficient cash on hand to continue to meet its short- and long-term strategic objectives, COVID-19 continues to impact nearly all geographies served by the Company to varying degrees. Given the magnitude of the uncertainty that COVID-19 has broadly placed on global markets, the pandemic’s long-term effects on the Company’s results and the Company’s ability to maintain service levels cannot currently be estimated. The Company will continue to assess the situation and take the appropriate actions to address the impact of COVID-19 on its operations.

During the first quarter of fiscal 2020, the Company commissioned third party led studies regarding the potential upgrading of the Company’s current worldwide ERP system. Chase is currently reviewing the data and recommendations provided by the study and may further utilize third-party engineering, IT and other professional services firms in the future for similar work, as well as work around the facilities rationalization and consolidation initiative. The Company recognized $150 in expense related to these services in the first nine months of fiscal 2020, with nothing recognized in the first nine months of fiscal 2021. Given the ongoing nature of the review, an estimate of future costs, including those that may be capitalized, cannot currently be determined.

During the third quarter of fiscal 2019, Chase began moving the pulling and detection operations from its Granite Falls, NC location to its Hickory, NC facility. This is in line with the Company’s ongoing initiative to consolidate its manufacturing plants and streamline its existing processes. At the time, the pulling and detection operations were the only Chase-owned production operations in Granite Falls, NC, with the remaining portions of the building being either utilized for research and development or leased to a third party. The process of moving, including moving internal research and development capabilities, was substantially completed during the second quarter of fiscal 2020. The Company recognized $559 in expense related to the move in the six-month period ended February 29, 2020, having recognized $526 in expense during the second half of fiscal 2019. This project is now substantively complete, and no costs were recognized in the second half of fiscal 2020 or in the nine months ended May 31, 2021, and any future costs related to this move are not anticipated to be significant to the condensed consolidated financial statements.

Significant Accounting Policies

The Company’s significant accounting policies are detailed in Note 1 — “Summary of Significant Accounting Policies” within Item 8 of the Company’s Annual Report on Form 10-K for the year ended August 31, 2020. Significant changes to these accounting policies as a result of adopting Accounting Standards Update ("ASU") No. 2016-13, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,” during the first quarter of fiscal 2021 are discussed within Note 2 — “Recent Accounting Standards” within this Current Quarterly Report on Form 10-Q.

Table of Contents

Note 2 — Recent Accounting Standards

Recently Adopted Accounting Pronouncements

In March 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting”. The ASU applies to all entities that have contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. The ASU provides optional expedients and exceptions for applying generally accepted accounting principles (GAAP) to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The expedients and exceptions provided by the ASU do not apply to contract modifications made and hedging relationships entered into or evaluated after December 31, 2022, except for hedging relationships existing as of December 31, 2022 for which an entity has elected certain optional expedients and that are retained through the end of the hedging relationship. The ASU is effective for all entities as of March 12, 2020 through December 31, 2022. ASU 2020-04 has not had, and the Company does not expect it to have in future periods, a material impact on the Company's condensed consolidated financial statements and disclosures.

In June 2016, the FASB issued ASU No. 2016-13, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,” which modifies the measurement approach for credit losses on financial assets measured on an amortized cost basis from an 'incurred loss' method to an 'expected loss' method. In November 2019, the FASB issued ASU 2019-11, “Codification Improvements to Topic 326, Financial Instruments – Credit Losses.” ASU 2019-11 is an accounting pronouncement that amends ASU 2016-13. This amendment provides clarity and improves the codification to ASU 2016-13. The pronouncements are concurrently effective for fiscal years beginning after December 15, 2019 and interim periods therein. The Company adopted ASU 2016-13 on September 1, 2020, using the modified retrospective transition method which resulted in no material impact on the condensed consolidated financial statements.

As a result of the adoption of ASU 2016-13, the Company has updated its critical accounting policy related to trade account receivables and allowances for credit losses effective September 1, 2020 from the critical accounting policies previously disclosed in our audited financial statements for the year ended August 31, 2020 as follows:

All trade account receivables are reported net of allowances for credit losses. The allowances for credit losses represent management’s best estimate of the credit losses expected from our trade account receivables over the life of the underlying assets. Assets with similar risk characteristics are pooled together for determination of their current expected credit losses. The Company regularly performs detailed reviews of our pooled assets to evaluate the collectability of receivables based on a combination of past, current, and future financial and qualitative factors that may affect customers’ ability to pay. In circumstances where the Company is aware of a specific customer’s inability to meet its financial obligations, a specific reserve is recorded against amounts due to reduce the recognized receivable to the amount reasonably expected to be collected.

Note 3 — Inventory

Inventory consisted of the following as of May 31, 2021 and August 31, 2020:


	May 31,		August 31,
	2021		2020
Raw materials	$	21,534	$	18,993
Work in process		6,017		7,761
Finished goods		10,844		12,304
Total Inventory	$	38,395	$	39,058

Table of Contents

Note 4 — Net Income Per Share

The Company has unvested share-based payment awards with a right to receive nonforfeitable dividends which are considered participating securities under ASC Topic 260, “Earnings Per Share.” The Company allocates earnings to participating securities and computes earnings per share using the two-class method. The determination of earnings per share under the two-class method is as follows:


	Three Months Ended May 31,				Nine Months Ended May 31,
	2021		2020		2021		2020

Basic Earnings per Share

Net income	$	14,289	$	9,908	$	34,297	$	25,149
Less: Allocated to participating securities		94		86		239		201
Net income available to common shareholders	$	14,195	$	9,822	$	34,058	$	24,948

Basic weighted average shares outstanding		9,386,814		9,363,559		9,381,433		9,357,176
Net income per share - Basic	$	1.51	$	1.05	$	3.63	$	2.67

Diluted Earnings per Share

Net income	$	14,289	$	9,908	$	34,297	$	25,149
Less: Allocated to participating securities		94		86		239		201
Net income available to common shareholders	$	14,195	$	9,822	$	34,058	$	24,948

Basic weighted average shares outstanding		9,386,814		9,363,559		9,381,433		9,357,176
Additional dilutive common stock equivalents		48,521		65,704		45,446		78,721
Diluted weighted average shares outstanding		9,435,335		9,429,263		9,426,879		9,435,897
Net income per share - Diluted	$	1.50	$	1.04	$	3.61	$	2.64

Included in the calculation of dilutive common stock equivalents are the unvested portion of restricted stock and stock options. For the three-month and nine-month periods ended May 31, 2021, stock options to purchase 17,947 and 59,346 shares of common stock, respectively, were outstanding but were not included in the calculation of diluted income per share because their inclusion would be anti-dilutive. For the three-month and nine-month periods ended May 31, 2020, stock options to purchase 17,913 and 11,841 shares of common stock, respectively, were outstanding but were not included in the calculation of diluted income per share because their inclusion would be anti-dilutive.

Table of Contents

Note 5 — Stock-Based Compensation

In August 2019, the Board of Directors of the Company approved the fiscal year 2020 Long Term Incentive Plan (“2020 LTIP”) for the executive officers and other members of management. The 2020 LTIP is an equity-based plan with a grant date of September 1, 2019 and contains (a) a restricted stock grant of 7,386 shares in the aggregate (of which 3,697 included a performance-based vesting component and were subject to adjustment as discussed below), with a vesting date of August 31, 2022, and (b) options to purchase 13,418 shares of common stock in the aggregate with an exercise price of $100.22 per share, vesting in three equal annual installments ending on August 31, 2022.

Based on the fiscal year 2020 financial results, 387 shares of restricted stock already granted under the 2020 LTIP were forfeited following the end of fiscal year 2020 in accordance with the performance measurement criteria. No further performance-based measurements apply to this award. Compensation expense for the 2020 LTIP awards is recognized on a ratable basis over the vesting period.

In August 2019, the Board of Directors of the Company approved equity retention agreements with certain executive officers. The equity-based retention agreements have a grant date of September 1, 2019 and contain the following equity components: (a) time-based restricted stock grant of 15,945 shares in the aggregate, and having a vesting date of August 31, 2022; and (b) options to purchase 53,642 shares of common stock in the aggregate with an exercise price of $100.22 per share. The options will cliff vest on August 31, 2022 and will expire on August 31, 2029. Compensation expense for both the restricted stock and the stock option components of the equity retention agreements is recognized on a ratable basis over the vesting period.

In August 2020, the Board of Directors of the Company approved the fiscal year 2021 Long Term Incentive Plan (“2021 LTIP”) for the executive officers and other members of management. The 2021 LTIP is an equity-based plan with a grant date of September 1, 2020 and initially contained the following equity components:

Restricted Shares — (a) a performance and service-based restricted stock grant of 3,798 shares in the aggregate, subject to adjustment based on fiscal 2021 results, with a vesting date of August 31, 2023. Compensation expense is recognized on a ratable basis over the vesting period based on quarterly probability assessments; and (b) a time-based restricted stock grant of 4,919 shares in the aggregate, with a vesting date of August 31, 2023. Compensation expense is recognized on a ratable basis over the vesting period.

Stock options — options to purchase 14,845 shares of common stock in the aggregate with an exercise price of $97.57 per share. The options will vest in three equal annual installments beginning on August 31, 2021 and ending on August 31, 2023. Of the options granted, 5,391 options will expire on August 31, 2030, and 9,454 options will expire on September 1, 2030. Compensation expense is recognized over the period of the award consistent with the vesting terms.

In the first quarter of 2021, restricted stock in the amount of 952 shares related to the second quarter of fiscal 2020 grant was forfeited in conjunction with the termination of employment of non-executive members of management of the Company.

In December 2020, restricted stock in the amount of 110 shares were granted to certain non-employee members of the board of directors in relation to their service on the board. These shares vested during the second fiscal quarter of 2021.

In January 2021, restricted stock in the amount of 4,409 shares and options to purchase 18,129 shares of common stock were forfeited in conjunction with the termination without cause of a now former executive of the Company. Options to purchase an additional 306 shares of common stock were forfeited in April 2021 related to this same termination.

Table of Contents

In February 2021, a performance and service-based restricted stock grant totaling 521 shares, a time-vesting restricted stock grant in the amount of 261 shares and options to purchase 749 shares of common stock with an exercise price of $104.04 per share were granted in conjunction with the appointment of a new executive of the Company. The restricted shares and stock options vest on the same terms as those granted under the 2021 LTIP in September 2020. Compensation expense is recognized over the period of the award consistent with the vesting terms.

In February 2021, as part of their standard compensation for board service, non-employee members of the Board received a total grant of 4,525 shares of restricted stock for service for the period from January 31, 2021 through January 31, 2022. The shares of restricted stock will vest at the conclusion of this service period. Compensation is being recognized on a ratable basis over the twelve-month vesting period.

In February 2021, restricted stock in the amount of 2,306 shares were granted to a consultant of the Company, with a two-year vesting term including continued service requirements. Compensation expense is recognized over the period of the award consistent with the vesting terms.

Note 6 — Segment Data and Foreign Operations

The Company is organized into three reportable operating segments: Adhesives, Sealants and Additives; Industrial Tapes; and Corrosion Protection and Waterproofing. The segments are distinguished by the nature of the products manufactured and how they are delivered to their respective markets.

The Adhesives, Sealants and Additives segment offers innovative and specialized product offerings consisting of both end-use products and intermediates that are used in, or integrated into, another company’s product. Demand for the segment’s product offerings is typically dependent upon general economic conditions. The Adhesives, Sealants and Additives segment leverages the core specialty chemical competencies of the Company and serves diverse markets and applications. The segment sells predominantly into the transportation, appliances, medical, general industrial and environmental market verticals. The segment’s products include moisture protective coatings and cleaners, and customized sealant and adhesive systems for electronics, polymeric microspheres, polyurethane dispersions and superabsorbent polymers. Beginning September 1, 2020, the Adhesives, Sealants and Additives segment includes the acquired operations of ABchimie, within the electronic and industrial coatings product line and beginning February 5, 2021, the acquired operations of ETi, within the functional additives product line.

The Industrial Tapes segment features wire and cable materials, specialty tapes and other laminated and coated products. The segment derives its competitive advantage through its proven chemistries, its diverse specialty offerings and the reliability its supply chain offers to end customers. These products are generally used in the assembly of other manufacturers’ products, with demand typically dependent upon general economic conditions. The Industrial Tapes segment sells mostly to established markets, with some exposure to growth opportunities through further development of existing products. Markets served include cable manufacturing, utilities and telecommunications, and electronics packaging. The segment’s offerings include insulating and conducting materials for wire and cable manufacturers, laminated durable papers, laminates for the packaging and industrial laminate markets, custom manufacturing services, pulling and detection tapes used in the installation, measurement and location of fiber optic cables and water and natural gas lines and cover tapes essential to delivering semiconductor components via tape-and-reel packaging.

The Corrosion Protection and Waterproofing segment is principally composed of project-oriented product offerings that are primarily sold and used as “Chase” branded products. End markets include new and existing infrastructure projects on oil, gas, water and wastewater pipelines, highways and bridge decks, water and wastewater containment systems, and commercial buildings. The segment’s products include protective coatings for pipeline applications, coating and lining systems for waterproofing and liquid storage applications, adhesives and sealants used in architectural and building envelope waterproofing applications, high-performance polymeric asphalt additives, and expansion joint systems for waterproofing applications in transportation and architectural markets. With sales generally dependent on outdoor project work, the segment experiences highly seasonal sales patterns.

Table of Contents

The following tables summarize information about the Company’s reportable segments:


	Three Months Ended May 31,						Nine Months Ended May 31,
	2021			2020			2021			2020
Revenue
Adhesives, Sealants and Additives	$	33,861		$	22,922		$	95,507		$	73,184
Industrial Tapes		32,249			31,752			87,085			91,931
Corrosion Protection and Waterproofing		13,483			10,197			32,624			32,140
Total	$	79,593		$	64,871		$	215,216		$	197,255

Income before income taxes
Adhesives, Sealants and Additives	$	10,982	(a)	$	6,704		$	31,098	(c)	$	20,936
Industrial Tapes		10,945			9,011			27,273			24,050	(e)
Corrosion Protection and Waterproofing		5,098			4,149			11,599			12,240
Total for reportable segments		27,025			19,864			69,970			57,226
Corporate and common costs		(9,282)			(7,337)	(b)		(25,385)	(d)		(23,823)	(f)
Total	$	17,743		$	12,527		$	44,585		$	33,403

Includes the following costs by segment:
Adhesives, Sealants and Additives
Interest	$	25		$	26		$	79		$	68
Depreciation		255			199			744			791
Amortization		2,715			2,340			7,931			7,033

Industrial Tapes
Interest	$	15		$	33		$	57		$	87
Depreciation		412			428			1,305			1,247
Amortization		387			450			1,160			1,350

Corrosion Protection and Waterproofing
Interest	$	28		$	8		$	68		$	23
Depreciation		157			144			432			449
Amortization		274			108			475			341

(a)

Includes $262 in loss on the upward adjustment of the performance-based earn out contingent consideration associated with the September 2020 acquisition of ABchimie and $22 in exit costs related to the movement of the sealants system business out of the Newark, CA location and into the Hickory, NC location during the third quarter of fiscal 2021

(b)

Includes $760 in gain related to the April 2020 sale of the Company’s Pawtucket, RI location, $183 in severance expense related to the May 2020 reduction in force, $85 in expenses related to the final transition out of the Pawtucket, RI facility, $75 of pension-related settlement costs due to the timing of lump-sum distributions and $20 in acquisition-related expense attributable to the September 2020 acquisition of ABchimie

(c)

Includes $995 in loss on the upward adjustment of the performance-based earn out contingent consideration associated with the September 2020 acquisition of ABchimie and $120 in exit costs related to the movement of the sealants system business out of the Newark, CA location and into the Hickory, NC location during the first nine months of fiscal 2021

(d)

Includes $128 in acquisition-related expense attributable to the February 2021 acquisition of the operations of ETi

(e)

Includes $559 in exit costs related to the movement of the pulling and detection business out of the Granite Falls, NC location and into the Hickory, NC location during the first nine months of fiscal 2020

(f)

Includes $150 of expense related to exploratory IT work performed to assess potential future upgrades to the companywide ERP system, a $760 gain related to the April 2020 sale of the Company’s Pawtucket, RI location, $183 in severance expense related to the May 2020 reduction in force, $85 in expenses related to the final transition out of the Pawtucket, RI facility, $75 of pension-related settlement costs due to the timing of lump-sum distributions and $153 in acquisition-related expense attributable to the September 2020 acquisition of ABchimie

Table of Contents

Total assets for the Company’s reportable segments as of May 31, 2021 and August 31, 2020 were:


	May 31,		August 31,
	2021		2020
Total Assets
Adhesives, Sealants and Additives	$	166,085	$	129,457
Industrial Tapes		70,036		71,229
Corrosion Protection and Waterproofing		30,744		32,642
Total for reportable segments		266,865		233,328
Corporate and common assets		123,369		113,502
Total	$	390,234	$	346,830

The Company’s products are sold worldwide. Revenue for the three- and nine-month periods ended May 31, 2021 and 2020 was attributed to operations located in the following countries:


	Three Months Ended May 31,				Nine Months Ended May 31,
	2021		2020		2021		2020
Revenue
United States	$	67,264	$	56,177	$	178,635	$	171,774
United Kingdom		6,184		5,070		19,208		14,489
All other foreign ⁽¹⁾		6,145		3,624		17,373		10,992
Total	$	79,593	$	64,871	$	215,216	$	197,255

(1)

Comprises sales originated from the Company’s French locations (including ABchimie for fiscal 2021), royalty revenue attributable to its licensed manufacturer in Asia, and Chase foreign manufacturing operations.

As of May 31, 2021 and 2020 the Company had long-lived assets (defined as tangible assets providing the Company with a future economic benefit beyond the current year or operating period, including buildings, equipment and leasehold improvements) and goodwill and intangible assets, less accumulated amortization, in the following countries:


	May 31,		August 31,
	2021		2020
Long-Lived Assets
United States
Property, plant and equipment, net	$	21,199	$	22,427
Goodwill and Intangible assets, less accumulated amortization		118,789		117,930

United Kingdom
Property, plant and equipment, net		2,352		2,320
Goodwill and Intangible assets, less accumulated amortization		4,192		4,403

All other foreign
Property, plant and equipment, net		1,134		827
Goodwill and Intangible assets, less accumulated amortization		26,093		1,269

Total
Property, plant and equipment, net	$	24,685	$	25,574
Goodwill and Intangible assets, less accumulated amortization	$	149,074	$	123,602

Table of Contents

Note 7 — Goodwill and Other Intangibles

The changes in the carrying value of goodwill were as follows:


	Adhesives, Sealants and Additives		Industrial Tapes		Corrosion Protection and Waterproofing		Consolidated
Balance at August 31, 2020	$	50,487	$	21,215	$	10,700	$	82,402
Acquisition of ABchimie		13,055		—		—		13,055
Acquisition of Emerging Technologies, Inc.		2,451		—		—		2,451
Foreign currency translation adjustment		536		—		13		549
Balance at May 31, 2021	$	66,529	$	21,215	$	10,713	$	98,457

The Company’s goodwill is allocated to each reporting unit based on the nature of the products manufactured by the respective business combinations that originally created the goodwill. The Company has identified a total of three reporting units, corresponding to its three operating segments, that are used to evaluate the possible impairment of goodwill. Assessments of possible impairment of goodwill are made when events or changes in circumstances indicate that the carrying value of the asset may not be recoverable through future operations. Additionally, testing for possible impairment of recorded goodwill and certain intangible asset balances is required annually. The amount and timing of any impairment charges based on these assessments require the estimation of future cash flows and the fair market value of the related assets based on management’s best estimates of certain key factors, including future selling prices and volumes; operating, raw material and energy costs; and various other projected operating and economic factors, including the anticipated future impact of the coronavirus disease 2019 (COVID-19) pandemic. When testing, fair values of the reporting units and the related implied fair values of their respective goodwill are established using discounted cash flows. The Company evaluates the possible impairment of goodwill annually during the fourth quarter, and whenever events or circumstances indicate the carrying value of goodwill may not be recoverable.

The Company has adopted ASU No. 2017-04 “Intangibles - Goodwill and Other Topics (Topic 350): Simplifying the Test for Goodwill Impairment.” The Company assesses goodwill for impairment by comparing the fair value of the reporting unit to its carrying amount. If the fair value of a reporting unit is less than its carrying value, an impairment loss, limited to the amount of goodwill allocated to that reporting unit, is recorded.

Intangible assets subject to amortization consisted of the following as of May 31, 2021 and August 31, 2020:


	Weighted Average		Gross Carrying		Accumulated		Net Carrying
	Amortization Period		Value		Amortization		Value
May 31, 2021
Patents and agreements	14.6	years	$	1,760	$	1,713	$	47
Formulas and technology	7.9	years		11,042		9,654		1,388
Trade names	5.9	years		8,871		8,191		680
Customer lists and relationships	9.2	years		117,537		69,035		48,502
			$	139,210	$	88,593	$	50,617

August 31, 2020
Patents and agreements	14.6	years	$	1,760	$	1,705	$	55
Formulas and technology	7.8	years		10,250		9,121		1,129
Trade names	5.8	years		8,575		7,781		794
Customer lists and relationships	9.1	years		98,966		59,744		39,222
			$	119,551	$	78,351	$	41,200

Table of Contents

Aggregate amortization expense related to intangible assets for the nine months ended May 31, 2021 and 2020 was $9,566 and $8,724 respectively. Estimated amortization expense for the remainder of fiscal year 2021 and for the next five years is as follows:


Years ending August 31,
2021 (remaining 3 months)	$	3,335
2022		11,862
2023		8,746
2024		7,538
2025		5,939
2026		5,144

Note 8 — Leases

Effective September 1, 2019 (the start of fiscal 2020), the Company adopted ASU 2016-02, Leases (Topic 842), using the modified retrospective approach and utilizing the effective date as its date of initial application. The Company has elected to apply the ‘package of practical expedients’ which allows it to not reassess i) whether existing or expired arrangements contain a lease, ii) the lease classification of existing or expired leases, or iii) whether previous initial direct costs would qualify for capitalization under the new lease standard.

At the inception of an arrangement, the Company determines whether the arrangement is or contains a lease based on the unique facts and circumstances present in the arrangement. Leases with a term greater than one year are recognized on the balance sheet as right-of-use (ROU) assets and short-term and long-term lease liabilities, as applicable. The Company does not have any financing leases that are material in nature.

Operating lease liabilities and their corresponding right-of-use assets are initially recorded based on the present value of lease payments over the expected remaining lease term. The interest rate implicit in lease contracts is typically not readily determinable. As a result, the Company utilizes its incremental borrowing rate to discount lease payments, which reflects the fixed rate at which the Company believes it could borrow on a collateralized basis the amount of the lease payments in the same currency, for a similar term, in a similar economic environment.

The Company has elected not to recognize leases with an original term of one year or less on the balance sheet. The Company typically only includes an initial lease term in its assessment of a lease arrangement. Options to renew a lease are not included in the Company’s assessment unless there is reasonable certainty that the Company will renew.

The following table presents the right-of-use asset and short-term and long-term lease liabilities amounts recorded on the condensed consolidated balance sheet as of May 31, 2021 and August 31, 2020:


	May 31,		August 31,
	2021		2020
Assets
Operating lease right-of-use asset	$	9,787	$	8,821

Liabilities
Current (accrued expense)	$	1,584	$	1,865
Operating lease long-term liabilities		7,601		6,395
Total lease liability	$	9,185	$	8,260

Table of Contents

Lease cost

The components of lease costs for the three and nine months ended May 31, 2021 and 2020 are as follows:


	Three Months Ended May 31,				Nine Months Ended May 31,
	2021		2020		2021		2020

Operating lease cost ^(a)	$	911	$	952	$	2,833	$	2,802

(a)

Includes short-term leases and variable lease costs (e.g. common area maintenance), which are immaterial.

Maturity of lease liability

The maturity of the Company's lease liabilities at May 31, 2021 was as follows:


	Future Operating
Year ending August 31,	Lease Payments
2021 (remaining 3 months)	$	469
2022		1,718
2023		1,564
2024		1,487
2025		1,326
2026 and thereafter		3,380
Less: Interest		(759)
Present value of lease liabilities	$	9,185

The weighted average remaining lease term and discount rates are as follows:


	May 31,			August 31,
	2021			2020
Lease Term and Discount Rate
Weighted average remaining lease term (years)
Operating leases		7.0			5.5
Weighted average discount rate (percentage)
Operating leases		3.1	%		3.1	%

Other Information

Supplemental cash flow information related to leases is as follows:


	Nine Months Ended May 31,
	2021		2020

Operating cash outflows from operating leases	$	1,797	$	1,818
Total cash paid for amounts included in the measurement of lease liabilities	$	1,797	$	1,818

Table of Contents

Note 9 — Revenue from Contracts with Customers

The Company accounts for revenue in accordance with ASC 606, “Revenue from Contracts with Customers.” This revenue is generated from the manufacture of specialty chemical products including coatings, linings, adhesives, sealants, specialty tapes, polymers and laminates. Certain of these manufactured products can incorporate customer-owned materials. The Company also recognizes, to a lesser extent, revenue through royalties and commissions from licensed manufacturers and from providing custom manufacturing-related services. The Company’s revenue recognition policies require the Company to make significant judgments and estimates. In applying the Company’s revenue recognition policy, determinations must be made as to when control of products passes to the Company’s customers, which can be either at a point in time or over time based on contractual terms with customers. Revenue is generally recognized at a point in time when control passes upon either shipment to or receipt by the customer of the Company’s products, while revenue is generally recognized over time when control of the Company’s products transfers to customers during the manufacturing process. The Company analyzes several factors, including but not limited to the nature of the products being sold and contractual terms and conditions in contracts with customers, to help the Company make such judgments about revenue recognition.

Contract Balances

The Company’s contract assets primarily relate to unbilled revenue for products currently in production at the Company’s facilities and which incorporate customer-owned material. Revenue is recognized in advance of billing to the customer in these specific circumstances, whereas billing is typically performed at the time of shipment to or receipt by the customer.

Contract assets are included in prepaid expenses and other current assets on the Company’s condensed consolidated balance sheet. The following table presents contract assets by reportable operating segment as of May 31, 2021 and August 31, 2020:


	May 31,		August 31,
	2021		2020
Contract Assets
Adhesives, Sealants and Additives	$	13	$	20
Industrial Tapes		46		21
Corrosion Protection and Waterproofing		86		41
Total	$	145	$	82

The Company did not have any contract liabilities as of May 31, 2021 and August 31, 2020.

Table of Contents

Disaggregated Revenue

The Company disaggregates revenue from customers by geographic region, as it believes this disclosure best depicts how the nature, amount, timing and uncertainty of the Company's revenue and cash flows are affected by economic factors. Disaggregated revenue by geographical region for the three and nine months ended May 31, 2021 and 2020 was as follows:


	Three Months Ended May 31, 2021
	Adhesives, Sealants		Industrial		Corrosion Protection		Consolidated
	and Additives		Tapes		and Waterproofing		Revenue
Revenue
North America	$	20,497	$	28,620	$	11,631	$	60,748
Asia		7,030		2,019		1,023		10,072
Europe		6,167		1,009		746		7,922
All other foreign		167		601		83		851
Total Revenue	$	33,861	$	32,249	$	13,483	$	79,593

	Nine Months Ended May 31, 2021
	Adhesives, Sealants		Industrial		Corrosion Protection		Consolidated
	and Additives		Tapes		and Waterproofing		Revenue
Revenue
North America	$	56,606	$	76,429	$	27,062	$	160,097
Asia		21,958		5,855		3,592		31,405
Europe		16,497		3,061		1,823		21,381
All other foreign		446		1,740		147		2,333
Total Revenue	$	95,507	$	87,085	$	32,624	$	215,216


	Three Months Ended May 31, 2020
	Adhesives, Sealants		Industrial		Corrosion Protection		Consolidated
	and Additives		Tapes		and Waterproofing		Revenue
Revenue
North America	$	15,094	$	28,137	$	7,635	$	50,866
Asia		4,541		2,239		1,737		8,517
Europe		3,201		840		750		4,791
All other foreign		86		536		75		697
Total Revenue	$	22,922	$	31,752	$	10,197	$	64,871

	Nine Months Ended May 31, 2020
	Adhesives, Sealants		Industrial		Corrosion Protection		Consolidated
	and Additives		Tapes		and Waterproofing		Revenue
Revenue
North America	$	49,135	$	81,811	$	25,323	$	156,269
Asia		13,268		5,642		4,419		23,329
Europe		10,422		2,386		2,201		15,009
All other foreign		359		2,092		197		2,648
Total Revenue	$	73,184	$	91,931	$	32,140	$	197,255

Table of Contents

Note 10 — Commitments and Contingencies

The Company is involved from time to time in litigation incidental to the conduct of its business. Although the Company does not expect that the outcome in any of these matters, individually or collectively, will have a material adverse effect on its financial condition, results of operations or cash flows, litigation is inherently unpredictable. Therefore, judgments could be rendered, or settlements agreed to that could adversely affect the Company’s operating results or cash flows in a particular period. The Company routinely assesses all its litigation and threatened litigation as to the probability of ultimately incurring a liability and records its best estimate of the ultimate loss in situations where it assesses the likelihood of loss as probable.

Note 11 — Pensions and Other Postretirement Benefits

The components of net periodic benefit cost for the three and nine months ended May 31, 2021 and 2020 were as follows:


	Three Months Ended May 31,				Nine Months Ended May 31,
	2021		2020		2021		2020
Components of net periodic benefit cost
Service cost	$	91	$	74	$	274	$	221
Interest cost		86		112		256		338
Expected return on plan assets		(97)		(98)		(293)		(294)
Amortization of prior service cost		1		1		3		3
Amortization of accumulated loss		164		174		492		522
Curtailment and settlement loss		—		75		—		75
Net periodic benefit cost	$	245	$	338	$	732	$	865

When funding is required, the Company’s policy is to contribute amounts that are deductible for federal income tax purposes. The Company has made contributions of $1,174 in the nine months ended May 31, 2021 to fund its obligations under its pension plans, and plans to make the necessary contributions over the remainder of fiscal 2021 to ensure the qualified plan continues to be adequately funded given the current market conditions, including conditions related to the coronavirus disease 2019 (COVID-19) pandemic. The Company made contributions of $1,170 in the nine months ended May 31, 2020.

Table of Contents

Note 12 — Fair Value Measurements

The Company defines fair value as the price that would be received to sell an asset or paid to transfer a liability (exit price) in an orderly transaction between market participants at the measurement date. The Company uses a three-tier fair value hierarchy, which classifies the inputs used in measuring fair values. These tiers are: Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions.

The Company utilizes the best available information in measuring fair value. Financial assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurement. The financial assets classified as Level 1 and Level 2 as of May 31, 2021 and August 31, 2020 represent investments that are restricted for use in nonqualified retirement savings plans for certain key employees and directors.

The following table sets forth the Company’s financial assets that were accounted for at fair value on a recurring basis as of May 31, 2021 and August 31, 2020:


				Fair value measurement category
				Quoted prices		Significant other		Significant
	Fair value			in active markets		observable inputs		unobservable inputs
	measurement date	Total		(Level 1)		(Level 2)		(Level 3)
Assets:
Restricted investments	May 31, 2021	$	2,038	$	1,796	$	242	$	—

Restricted investments	August 31, 2020	$	1,619	$	1,395	$	224	$	—

The following table presents the fair value of the Company’s liabilities that are accounted for at fair value on a recurring basis as of May 31, 2021 and August 31, 2020:


				Fair value measurement category
				Quoted prices		Significant other		Significant
	Fair value			in active markets		observable inputs		unobservable inputs
	measurement date	Total		(Level 1)		(Level 2)		(Level 3)
Liabilities:
Long-term debt	May 31, 2021	$	—	$	—	$	—	$	—
Contingent consideration	May 31, 2021	$	1,939	$	—	$	—	$	1,939

Long-term debt	August 31, 2020	$	—	$	—	$	—	$	—
Contingent consideration	August 31, 2020	$	—	$	—	$	—	$	—

The long-term debt (including any current portion of long-term debt) had no outstanding balance as of May 31, 2021 and August 31, 2020. The carrying value of the long-term debt approximates its fair value, as the interest rate is set based on the movement of the underlying market rates. See Note 16 to the condensed consolidated financial statements for additional information on long-term debt.

In connection with accounting for the ABchimie acquisition on September 1, 2020, the Company recorded a contingent consideration liability included within Other liabilities on the condensed consolidated balance sheet of €780 (approximately $928) on the acquisition date, representing the fair value of contingent consideration payable upon the achievement of a performance-based target. The contingent consideration liability was valued using a Monte Carlo simulation model in an option pricing framework based on key inputs that are not all observable in the market, which represents a Level 3 measurement within the fair value hierarchy. The Company assesses the fair value of the contingent consideration liability at each reporting period. Any subsequent changes in the estimated fair value of the liability are reflected in Loss (gain) on contingent consideration on the condensed consolidated statement of operations until the liability is settled. As of May 31, 2021, the liability increased to $1,939 predominantly due to changes in non-market data assumptions as well as a shorter period to the payment date. See Note 17 to the condensed consolidated financial statements for additional information on the acquisition of ABchimie.

Table of Contents

Note 13 — Accumulated Other Comprehensive Income

The changes in accumulated other comprehensive income (loss), net of tax, were as follows:


			Change in Funded		Foreign Currency
	Restricted		Status of		Translation
	Investments		Pension Plans		Adjustment		Total
Balance at August 31, 2019	$	154	$	(6,271)	$	(8,207)	$	(14,324)

Other comprehensive gains (losses) before reclassifications (1)		29		—		318		347
Reclassifications to net income of previously deferred (gains) losses (2)		(24)		444		—		420
Other comprehensive income (loss)		5		444		318		767

Adoption of ASU 2018-02		—		(1,388)		—		(1,388)

Balance at May 31, 2020	$	159	$	(7,215)	$	(7,889)	$	(14,945)


Balance at August 31, 2020	$	269	$	(8,317)	$	(5,044)	$	(13,092)

Other comprehensive gains (losses) before reclassifications (3)		226		—		3,273		3,499
Reclassifications to net income of previously deferred (gains) losses (4)		(40)		371		—		331
Other comprehensive income (loss)		186		371		3,273		3,830

Balance at May 31, 2021	$	455	$	(7,946)	$	(1,771)	$	(9,262)

(1)

Net of tax benefit of $11, $0 and $0, respectively.

(2)

Net of tax expense of $8, tax benefit of $156 and $0, respectively.

(3)

Net of tax benefit of $77, $0 and $0, respectively.

(4)

Net of tax expense of $14, tax benefit of $124 and $0, respectively.

Table of Contents

The following table summarizes the reclassifications from accumulated other comprehensive income (loss) to the unaudited condensed consolidated statements of income:



	Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive
	Income (Loss) into Income
	Three Months Ended May 31,				Nine Months Ended May 31,				Location of Gain (Loss) Reclassified from Accumulated
	2021		2020		2021		2020		Other Comprehensive Income (Loss) into Income
Gains on Restricted Investments:
Realized loss (gain) on sale of restricted investments	$	(5)	$	(4)	$	(54)	$	(32)	Selling, general and administrative expenses
Tax expense (benefit)		1		1		14		8
Gain net of tax	$	(4)	$	(3)	$	(40)	$	(24)

Loss on Funded Pension Plan adjustments:
Amortization of prior pension service costs and unrecognized losses		165		175		495		525	Other income (expense)
Settlement and curtailment loss		—		75		—		75	Other income (expense)
Tax expense (benefit)		(41)		(65)		(124)		(156)
Loss net of tax	$	124	$	185	$	371	$	444

Total net loss reclassified for the period	$	120	$	182	$	331	$	420

Table of Contents

Note 14 — Income Taxes

For the three and nine months ended May 31, 2021, the Company’s recognized effective tax rate was 19.5% and 23.1%, respectively. For the three and nine months ended May 31, 2020, the Company’s recognized and effective tax rate was 20.9% and 24.7%, respectively.

The Company has applied the U.S. statutory Federal rate of 21%, enacted as part of the Tax Cuts and Jobs Act (the “Tax Act”) in December 2017, for both the quarters and nine-month periods ended May 31, 2021 and 2020.

During the quarter ended November 30, 2018 (the first quarter of fiscal 2019), the Company began recognizing an additional component of total Federal tax expense, the tax on Global Intangible Low-Taxed Income (“GILTI”) provision of the Tax Act, which became applicable to the Company in fiscal 2019. The Company elected to account for GILTI as a period cost, and therefore included GILTI expense in the effective tax rate calculation. This provision did not have a material effect on the effective tax rate for the quarters and nine-month periods ended May 31, 2021 and 2020. Additionally, the Company concluded that the Base Erosion and Anti Abuse Tax (“BEAT”) provision of the Tax Act, which also became applicable to the Company in fiscal 2019, had no effect on its effective tax rate for the nine-month periods ended May 31, 2021 and 2020.

On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) was enacted in response to the COVID-19 pandemic. The CARES Act, among other things, included a technical correction to the Tax Act which will allow accelerated deductions for qualified improvement property. The Company is currently evaluating the impact of the CARES Act, but at present does not expect that the qualified improvement property correction or other provisions of the CARES Act will result in a material tax benefit in future periods. The CARES Act had no material effect on the effective tax rate for the first nine months of fiscal 2021 or 2020.

In July 2020, the United States Internal Revenue Service (“IRS”) released final regulations (TD 9901) that ease documentation standards and provide greater flexibility for taxpayers claiming the deduction for Foreign-Derived Intangible Income (“FDII”). During both the three and nine months ended May 31, 2021, the Company’s effective tax rate included an FDII deduction benefit of $1,696. Also during the three and nine months ended May 31, 2021, the Company favorably resolved multiple uncertain tax positions and established international management fee charges which resulted in $933 of tax benefit and $1,229 of tax expense, respectively.

Note 15 — Operations Optimization Costs

Relocation of Adhesives Systems Manufacturing to O'Hara Township, PA

During the third quarter of fiscal 2021, Chase announced to the employees at its Woburn, MA location that its adhesives systems operations, part of the Adhesives, Sealants and Additives segment’s electronic and industrial coatings product line, would be consolidating into the Company’s existing O'Hara Township, PA location. This rationalization and consolidation initiative-related announcement aligns with the second quarter announcement of the Company’s plan to move its sealant systems production from Newark, CA to its location in Hickory, NC, described in more detail below. Chase Corporation obtained both the adhesive and sealants systems as part of its fiscal 2017 acquisition of the operations of Resin Designs. No expense was recognized related to this initiative during the third fiscal quarter, with the majority of future costs anticipated to occur in the first half of fiscal 2022.

Relocation of Sealants Systems Manufacturing to Hickory, NC

During the second quarter of fiscal 2021, Chase began moving the sealant systems operations, part of the Adhesives, Sealants and Additives segment’s electronic and industrial coatings product line, from its Newark, CA location to its Hickory, NC facility. This is in line with the Company’s ongoing initiative to consolidate its manufacturing plants and streamline its existing processes. The sealant systems operations and Newark, CA location came to Chase Corporation as part of the fiscal 2017 acquisition of the operations of Resin Designs, and the Company’s lease there terminates in the current fiscal year. The Company recognized $22 and $120 in expense related to the move in the three-month and nine-month periods, respectively, ended May 31, 2021.

Table of Contents

COVID-19 Related Cost Structure Changes

During the third fiscal quarter of 2020 (prior year), the Company implemented changes in its cost structure designed to address market changes brought on, in part, by COVID-19. These changes included a targeted reduction of approximately 4.5% of the Company’s global workforce. This reduction, which was contemplated pre-pandemic but catalyzed by COVID-19, resulted in the recognition of $183 in severance costs during the third quarter of 2020. The reduction in force, which impacted operations in the Blawnox, PA, Hickory, NC, Lenoir, NC, Evanston, IL, Oxford, MA and Westwood, MA facilities, was effective May 7, 2020.

IT Studies Related to the Upgrade of the Company’s Worldwide ERP System

During the first quarter of fiscal 2020, the Company commissioned third party led studies regarding the potential upgrading of the Company’s current worldwide ERP system. Chase is currently reviewing the data and recommendations provided by the study and may further utilize third-party engineering, IT and other professional services firms in the future for similar work, as well as work around its facilities rationalization and consolidation initiative. The Company recognized $150 in expense related to these services in the first nine months of fiscal 2020, with nothing recognized in the first nine months of fiscal 2021. Given the ongoing nature of the review, an estimate of future costs, including those that may be capitalized, cannot currently be determined.

Relocation of Pulling and Detection Manufacturing to Hickory, NC

During the third quarter of fiscal 2019, Chase began moving the pulling and detection operations from its Granite Falls, NC location to its Hickory, NC facility. This is in line with the Company’s ongoing initiative to consolidate its manufacturing plants and streamline its existing processes. At the time, the pulling and detection operations were the only Chase-owned production operations in Granite Falls, NC, with the remaining portions of the building being either utilized for research and development or leased to a third party. The process of moving, including moving internal research and development capabilities, was substantially completed during the second quarter of fiscal 2020. The Company recognized $559 in expense related to the move in the six-month period ended February 29, 2020, having recognized $526 in expense during the second half of fiscal 2019. This project is now substantively complete, and no costs were recognized in the second half of fiscal 2020 or the nine months ended May 31, 2021, and any future costs related to this move are not anticipated to be significant to the condensed consolidated financial statements.

Closure and Sale of Pawtucket, RI Facility

On June 25, 2018, the Company announced to its employees the planned closing of its Pawtucket, RI manufacturing facility effective August 31, 2018. This is in line with the Company’s ongoing efforts to consolidate its manufacturing plants and streamline its existing processes. The manufacture of products previously produced in the Pawtucket, RI facility was substantially moved to Company facilities in Oxford, MA and Lenoir, NC during a two-month transition period. The Company completed the sale of its Pawtucket, RI location to a third-party in April 2020, for net proceeds totaling $1,810. This transaction resulted in a gain of $760 which was recorded during the third quarter of fiscal 2020. Also, during the third quarter of fiscal 2020, the Company recognized $85 in final Pawtucket, RI transition and exit costs, with no further costs related to this initiative anticipated in future periods.

Table of Contents

Note 16 — Long-Term Debt

On December 15, 2016, the Company entered into an Amended and Restated Credit Agreement (the “Credit Agreement”) with Bank of America, acting as administrative agent, and with participation from Citizens Bank and JPMorgan Chase Bank (collectively with Bank of America, the “Lenders”). The Credit Agreement is an all-revolving credit facility with a borrowing capacity of $150,000, which can be increased by an additional $50,000 at the request of the Company and the individual or collective option of any of the Lenders. The facility matures December 15, 2021 (the second quarter of fiscal 2022). The Credit Agreement contains customary affirmative and negative covenants that, among other things, restrict the Company’s ability to incur additional indebtedness and require lender approval for acquisitions by the Company and its subsidiaries over a certain size. It also requires the Company to maintain certain financial ratios, including a consolidated net leverage ratio (as defined in the facility) of no more than 3.25 to 1.00, and a consolidated fixed charge coverage ratio (as defined in the facility) of at least 1.25 to 1.00. The Company was compliant with its debt covenants as of May 31, 2021. The Credit Agreement is guaranteed by all of Chase’s direct and indirect domestic subsidiaries, which collectively had a carrying value of $271,705 at May 31, 2021. The Company entered into the Credit Agreement both to refinance its previously existing term loan and revolving line of credit, and to provide for additional liquidity to finance potential acquisitions, working capital, capital expenditures, and for other general corporate purposes.

The applicable interest rate for the revolver portion of the Credit Agreement (the “Revolving Facility”) and any Term Loan (defined below) is based on the effective London Interbank Offered Rate (LIBOR) plus an additional amount in the range of 1.00% to 1.75%, depending on the consolidated net leverage ratio of Chase and its subsidiaries. At May 31, 2021, there was no outstanding principal balance, and therefore no applicable interest rate. The Credit Agreement has a five-year term with interest payments due at the end of the applicable LIBOR period (but in no event less frequently than the three-month anniversary of the commencement of such LIBOR period) and principal payment due at the expiration of the agreement, December 15, 2021. In addition, the Company may elect a base rate option for all or a portion of the Revolving Facility, in which case interest payments shall be due with respect to such portion of the Revolving Facility on the last business day of each quarter.

Subject to certain conditions set forth in the Credit Agreement, the Company may elect to convert all or a portion of the outstanding Revolving Facility into a term loan (each, a “Term Loan”), which shall be payable quarterly in equal installments sufficient to amortize the original principal amount of such Term Loan on a seven year amortization schedule; provided, however, that the final principal repayment installment shall be repaid on December 15, 2021 and in any event shall be in an amount equal to the aggregate principal amount of all Term Loans outstanding on such date. Prepayment is allowed by the Credit Agreement at any time during the term of the agreement, subject to customary notice requirements.

The Company expects to renew this facility, or enter into a new facility, prior to its expiration to maintain Chase’s ability to support its strategic initiatives.

Table of Contents

Note 17 – Acquisitions

Acquisition of Emerging Technologies, Inc.

On February 5, 2021, the Company acquired certain assets of Emerging Technologies, Inc. (“ETi”), a superabsorbent polymers solutions provider, located in Greensboro, NC. The business was acquired for a purchase price of $9,997, comprising $8,997 paid on February 5, 2021 and an accrual of $1,000 to be paid out up to eighteen months after the purchase, subsequent to final working capital adjustments, and excluding acquisition-related costs. As part of this transaction, Chase acquired substantially all working capital and fixed assets of the business and entered a multi-year lease at ETi’s existing location. The Company expensed $128 of acquisition-related costs during the three-month period ended February 28, 2021 associated with this acquisition. The purchase was funded with available cash on hand. ETi is a solutions provider and formulator of absorbent polymers for use in the packaging, recreational, consumer, and sanitation markets. The acquisition broadens the Company’s superabsorbent polymers product offerings and formulation capabilities while expanding its market reach. The Company is currently in the process of finalizing purchase accounting regarding a final allocation of the purchase price to tangible and identifiable intangible assets assumed, and anticipates completion within fiscal 2021. Since the effective date of the acquisition, the financial results of ETi’s acquired operations have been included in the Company’s financial statements within the functional additives product line, contained within the Adhesives, Sealants and Additives operating segment. The ETi acquisition does not represent a significant business combination so pro forma financial information is not provided.

The excess of the purchase price over the net tangible and intangible assets acquired resulted in preliminary goodwill of $2,451 that is largely attributable to the synergies and economies of scale from combining the operations, technologies and research and development capabilities of ETi and Chase, particularly as they pertain to the expansion of the Company's product and service offerings, the established workforce and marketing efforts. This goodwill is deductible for income tax purposes.

Acquisition of ABchimie

On September 1, 2020 (first day of fiscal 2021), the Company acquired all the capital stock of ABchimie for €18,654 (approximately $22,241 at the time of the transaction) net of cash acquired, subsequent to final working capital adjustment, excluding acquisition-related costs totaling $274 recognized in fiscal 2020 (with $20 and $153 recognized in the three- and nine-month periods ended May 31, 2020) and with a performance-based earn out potentially worth an additional €7,000 (approximately $8,330 at the time of the transaction). The Company accrued $1,939 at May 31, 2021 within Other liabilities on the condensed consolidated balance sheet related to its current estimate of the earn out. Following its initial recording at the acquisition date, a $262 and $995 increase in the performance-based earn out accrual was recorded within Loss (gain) on contingent consideration in the condensed consolidated statement of operations for the three and nine months ended May 31, 2021, respectively. ABchimie is a Corbelin, France headquartered solutions provider for the cleaning and protection of electronic assemblies, with ‎further formulation, production, and research and development capabilities‎. The transaction was funded with available cash on hand. The financial results of the business are included in the Company's fiscal 2021 financial statements within the Adhesives, Sealants and Additives operating segment in the electronic and industrial coatings product line. The Company is currently in the process of finalizing purchase accounting, regarding a final allocation of the purchase price to tangible and identifiable intangible assets assumed, including finalizing the recording of deferred taxes, and anticipates completion within fiscal 2021. The ABchimie acquisition does not represent a significant business combination so pro forma financial information is not provided.

The excess of the purchase price over the net tangible and intangible assets acquired resulted in goodwill preliminarily measured at $13,055 that is largely attributable to the synergies and economies of scale from combining the operations, technologies and research and development capabilities of ABchimie and Chase, particularly as they pertain to the expansion of the Company's product and service offerings, the established workforce and marketing efforts. A portion of this goodwill is deductible in the U.S. for calculation of GILTI period costs but is nondeductible for French income tax purposes.

Table of Contents

Item 2 — Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion provides an analysis of the Company’s financial condition and results of operations and should be read in conjunction with the Condensed Consolidated Financial Statements and notes thereto included in Item 1 of Part I of this Quarterly Report on Form 10-Q and with the Company’s Annual Report on Form 10-K filed for the fiscal year ended August 31, 2020.

Overview

General

Strong revenue in the quarter and nine-month period ended May 31, 2021 resulted in improvements in operating income and net income compared to the prior year periods. All three of Chase Corporation’s operating segments achieved top-line improvement over the COVID-19 affected third quarter of fiscal 2020. The Adhesives, Sealants and Additives segment led the improvement by achieving both organic and inorganic growth, with sales into automotive, industrial, medical and consumer markets, and continued an upward trajectory in international markets. The results of both the Company’s current year acquisitions (the February 2021 acquisition of the operations of Emerging Technologies, Inc. (“ETi”) and the September 2020 acquisition of ABchimie) are reported under the Adhesives, Sealants and Additives segment and combined provided accretive results for both the quarter and year-to-date period. The Industrial Tapes and Corrosion Protection and Waterproofing segments achieved recovery in sales over the prior year. The Corrosion Protection and Waterproofing sales in the third quarter brought the year-to-date total over the prior year-to-date period with domestic waterproofing projects work leading the rebound. However, challenges resulting from the global economic disruptions caused by the COVID-19 pandemic during the first nine months of fiscal 2021 resulted in the Industrial Tapes segment unable to surpass prior year sales results on a year-to-date basis. All of Chase Corporation’s segments are subject to current global raw material inflationary pressures and supply chain challenges, and the Company, in line with customer agreements, is addressing this by instituting customer price adjustments across impacted product lines in an effort to protect gross margins.

Business Development

During the third quarter of fiscal 2021, Chase announced to the employees at its Woburn, MA location that its adhesives systems operations would be consolidating into the Company’s existing O'Hara Township, PA location. This rationalization and consolidation initiative-related announcement aligns with the second quarter announcement of the Company’s plan to move its sealant systems production from Newark, CA to its location in Hickory, NC. Chase Corporation obtained both the adhesive and sealants systems as part of its fiscal 2017 acquisition of the operations of Resin Designs.

On February 5, 2021, the Company acquired certain assets of Emerging Technologies, Inc. (“ETi”), a Greensboro, NC-located solutions provider and formulator of absorbent polymers for use in the packaging, recreational, consumer, and sanitation markets. Following its fiscal 2018 acquisition of Zappa Stewart, the acquisition of ETi expands Chase Corporation’s market share in the growing superabsorbent polymers vertical. This second quarter acquisition comes following the September 1, 2020 purchase of ABchimie, a Corbelin, France-headquartered solutions provider for the cleaning and protection of electronic assemblies, with additional formulation, production, and research and development capabilities. Both the fiscal 2021 acquisitions were funded with available cash on hand and broaden the Company’s specialty chemical offerings within the Adhesives, Sealants, and Additives reporting segment with high performance, environmentally-friendly technologies that are complementary to Chase’s existing product offerings.

Table of Contents

Revenue by Segment

Chase Corporation has three reportable operating segments as summarized below:


Segment	Product Lines	Manufacturing Focus and Products
Adhesives, Sealants and Additives	Electronic and Industrial Coatings Functional Additives (1)	Protective coatings, including moisture protective coatings and cleaning chemistries, and customized sealant and adhesive systems for electronics; polyurethane dispersions, polymeric microspheres and superabsorbent polymers.
Industrial Tapes	Cable Materials Specialty Products Pulling and Detection Electronic Materials	Protective tape and coating products and services, including insulating and conducting materials for wire and cable manufacturers; laminated durable papers, packaging and industrial laminate products and custom manufacturing services; pulling and detection tapes used in the installation, measurement and location of fiber optic cables and water and natural gas lines; cover tapes essential to delivering semiconductor components via tape-and-reel packaging.
Corrosion Protection and Waterproofing	Coating and Lining Systems Pipeline Coatings Building Envelope Bridge and Highway	Protective coatings and tape products, including coating and lining systems for use in liquid storage and containment applications; protective coatings for pipeline and general construction applications; adhesives and sealants used in architectural and building envelope waterproofing applications; high-performance polymeric asphalt additives and expansion and control joint systems for use in the transportation and architectural markets.

(1)

Formerly referred to as the specialty chemical intermediates product line

Revenue from the Adhesives, Sealants and Additives segment increased for the third quarter and year-to-date period versus the prior year. Driven by Asian and European markets showing growth and the inorganic boost provided by the acquired operations of ABchimie, sales volumes within the electronic and industrial coatings product line increased. The Company’s North American-focused functional additives product line sales also experienced both organic and inorganic volume growth over both the comparative periods, with the operations of ETi added to the product line following its February 5, 2021 acquisition.

Sales showed recovery in the Industrial Tapes segment for the quarter ended May 31, 2021 over the COVID-19 impacted third quarter of the prior year, but remained below the prior year for the nine-month period ended May 31, 2021, with the cable materials, specialty products and pulling and detection product lines driving the top-line remission for the year-to-date period. The cable materials, specialty products and pulling and detection product lines all have a North American concentration, with the specialty products sales reductions further impacted in the year-to-date period by the Company’s prior year planned exit from providing low margin transitional toll manufacturing services to the purchaser of the structural composites rod and the fiber optical cable components businesses. By contrast, for the third quarter of fiscal 2021 the specialty products, pulling and detection and cable materials product lines had sales up from the prior year period. The Company’s electronic materials product line, which sells nearly exclusively to Asian markets, saw a sales volume decrease for the current year third quarter, but remained above the prior year on a year-to-date basis.

The Corrosion Protection and Waterproofing segment’s sales increased compared to both the third quarter and the first nine months of the prior year. The coating and lining systems and building envelope product lines were favorable to the prior year for both the current quarter and year-to-date period, with the pipeline coatings product line favorable for the third quarter, but remaining behind on a year-to-date basis. The bridge and highway product line sales were unfavorable to the third quarter and the first nine months of the prior year.

Table of Contents

Balance Sheet

Chase Corporation’s balance sheet remained strong on May 31, 2021, with cash on hand of $102,947,000, and a current ratio of 7.2. Favorable third quarter cash flow generation resulted in higher cash provided by operating activities over the prior year for both the quarter and year-to-date period. The Company’s cash position remains healthy, with cash flow from operations more than offsetting the costs to acquire ETi and ABchimie during the nine-month period.

The Company held no outstanding balance on its $150,000,000 revolving credit facility as of May 31, 2021. The revolving credit facility allows for the Company to pay down debt with excess cash, while retaining access to immediate liquidity to fund future accretive activities, including mergers and acquisitions, as they are identified. Chase’s current credit facility matures in December 2021. The Company expects to enter a new facility within the current fiscal year, prior to the current facility’s expiration, to maintain its ability to support Chase’s strategic initiatives.

Table of Contents

Results of Operations

Revenue and Income before Income Taxes by Segment were as follows (dollars in thousands):


				% of					% of					% of					% of
	Three Months Ended			Total		Three Months Ended			Total		Nine Months Ended			Total		Nine Months Ended			Total
	May 31, 2021			Revenue		May 31, 2020			Revenue		May 31, 2021			Revenue		May 31, 2020			Revenue

Revenue
Adhesives, Sealants and Additives	$	33,861		43	%	$	22,922		35	%	$	95,507		44	%	$	73,184		37	%
Industrial Tapes		32,249		41	%		31,752		49	%		87,085		40	%		91,931		47	%
Corrosion Protection and Waterproofing		13,483		17	%		10,197		16	%		32,624		15	%		32,140		16	%
Total	$	79,593				$	64,871				$	215,216				$	197,255

				% of					% of					% of					% of
	Three Months Ended			Segment		Three Months Ended			Segment		Nine Months Ended			Segment		Nine Months Ended			Segment
	May 31, 2021			Revenue		May 31, 2020			Revenue		May 31, 2021			Revenue		May 31, 2020			Revenue
Income before income taxes
Adhesives, Sealants and Additives	$	10,982	(a)	32	%	$	6,704		29	%	$	31,098	(c)	33	%	$	20,936		29	%
Industrial Tapes		10,945		34	%		9,011		28	%		27,273		31	%		24,050	(e)	26	%
Corrosion Protection and Waterproofing		5,098		38	%		4,149		41	%		11,599		36	%		12,240		38	%
Total for reportable segments		27,025		34	%		19,864		31	%		69,970		33	%		57,226		29	%
Corporate and Common Costs		(9,282)					(7,337)	(b)				(25,385)	(d)				(23,823)	(f)
Total	$	17,743		22	%	$	12,527		19	%	$	44,585		21	%	$	33,403		17	%

Note: Some percentage of revenue amounts may not sum due to rounding

(a)

(b)

(c)

(d)

Includes $128 in acquisition-related expense attributable to the February 2021 acquisition of the operations of ETi

(e)

(f)

Table of Contents

Total Revenue

Total revenue increased $14,722,000 or 23% to $79,593,000 for the quarter ended May 31, 2021, compared to $64,871,000 in the same quarter of the prior year. Total revenue increased $17,961,000 or 9% to $215,216,000 in the fiscal year-to-date period compared to $197,255,000 in the same period in fiscal 2020.

Revenue in the Company’s Adhesives, Sealants and Additives segment increased $10,939,000 or 48% and $22,323,000 or 31% in the current quarter and year-to-date period, respectively. Organic revenue growth accounted for $7,229,000 and $15,380,000 of the segment’s overall third quarter and year-to-date period sales increases, respectively. The increases in revenue from the Adhesives, Sealants and Additives segment in fiscal 2021 for the current quarter and year-to-date period, respectively, were primarily due to the electronic and industrial coatings product line’s $7,301,000 and $17,963,000 organic and inorganic increases. The operations of ABchimie, acquired September 1, 2020 (first day of fiscal 2021), provided the product line accretive top-line gains, while strong organic gains were seen both domestically and internationally. Also positively impacting the segment’s sales were organic and inorganic increases in revenue from the North American-focused functional additives product line totaling $3,638,000 and $4,360,000 in the current quarter and year-to-date period. The functional additives product line sales totals included the operations of ETi, following its acquisition on February 5, 2021 (second quarter of fiscal 2021).

Revenue in the Industrial Tapes segment increased $497,000 or 2% in the current quarter but decreased $4,846,000 or 5% for the year-to-date period. The net changes in revenue for the segment were primarily due to the following: (a) revenue increase of $493,000 for the quarter but a reduction of $261,000 for the year-to-date period for the specialty products product line, as the Company ended its arrangement to provide low margin transitional toll manufacturing services in the second quarter of fiscal 2020 (prior year); (b) the pulling and detection tapes product line saw sales growth of $136,000 over the prior year quarter but a reduction of $229,000 for the year-to-date period on lower sales volume; (c) the North American-focused cable materials product line achieved a sales volume and price increase of $94,000 for the quarter but remained $4,529,000 behind for the year-to-date period, with both COVID-19 and certain exposure to oil and gas markets negatively impacting year-to-date results; and (d) the electronic materials product line, which has a nearly exclusive Asian end-market, saw a reduction of $226,000 for the quarter but remained $173,000 above the prior year-to-date period.

Compared to the prior year third quarter and year-to-date period, revenue from the Corrosion Protection and Waterproofing segment increased $3,286,000 or 32% and $484,000 or 2%, respectively. The segment’s sales increases in the current quarter and year-to-date period were predominantly driven by: (a) the coating and lining systems product line sales increases of $2,542,000 and $1,652,000, with recovery and growth achieved following winter weather events which impacted the Houston, TX manufacturing facility and the surrounding region in the second quarter of fiscal 2021; and (b) the building envelope product line’s sales increases of $518,000 and $208,000, respectively. While achieving revenue growth of $492,000 over the prior year third quarter, the pipeline coatings product line remained $898,000 behind the prior year to-date period, with the Company’s North American operations effected by a net prolonged decrease in worldwide oil and gas prices, and with the Rye, U.K.-based facility’s Middle East sales prospects and margin also negatively impacted by energy prices during the current year periods. The bridge and highway product line sales saw reductions of $266,000 and $478,000 compared to the prior year third quarter and year-to-date period on lower project demand.

Table of Contents

Cost of Products and Services Sold

Cost of products and services sold increased $6,623,000 or 17% to $46,312,000 for the quarter ended May 31, 2021, compared to $39,689,000 in the prior year quarter. Cost of products and services sold increased $4,694,000 or 4% to $126,832,000 in the first nine months of fiscal 2021, compared to $122,138,000 in the comparative year-to-date period.

The following table summarizes the cost of products and services sold as a percentage of revenue for each of Chase Corporation’s reportable operating segments:


	Three Months Ended May 31,				Nine Months Ended May 31,
Cost of products and services sold	2021		2020		2021		2020
Adhesives, Sealants and Additives	56	%	57	%	55	%	57	%
Industrial Tapes	62		67		64		68
Corrosion Protection and Waterproofing	55		54		57		55
Total Company	58	%	61	%	59	%	62	%

Cost of products and services sold in the Adhesives, Sealants and Additives segment was $18,850,000 and $52,461,000 in the current quarter and year-to-date period compared to $13,044,000 and $41,831,000 in the comparable periods in the prior year. Cost of products and services sold in the Industrial Tapes segment was $20,043,000 and $55,853,000 in the current quarter and year-to-date period compared to $21,118,000 and $62,640,000 in the same periods in the prior year. Cost of products and services sold in the Corrosion Protection and Waterproofing segment was $7,419,000 and $18,518,000 for the quarter and year-to-date period ended May 31, 2021, compared to $5,527,000 and $17,667,000 in the comparable periods of the prior year.

As a percentage of revenue, cost of products and services sold was reduced for both the Adhesives, Sealants and Additives and Industrial Tapes segments and increased for the Corrosion Protection and Waterproofing segment as compared to the third quarter and first nine months of the prior year. These changes in relative gross margin were primarily due to: (a) more favorable sales mixes in the Adhesives, Sealants and Additives and Industrial Tapes segments, as higher margin products and offerings constituted a comparatively higher portion of total sales; and (b) net production and operational efficiencies realized in the Adhesives, Sealants and Additives and Industrial Tapes segments for the current quarter and year-to-date period, including those gained in part through the facility rationalization and consolidation initiative. All of Chase Corporation’s segments are subject to current global raw material inflationary pressures and supply chain challenges, and the Company, in line with customer agreements, is addressing this by instituting customer price adjustments across affected product lines.

With the composition of the Company’s finished goods and the markets it serves, the costs of certain commodities (including petroleum-based solvents, films, yarns, polymers and nonwovens, aluminum and copper foils, specialty papers, and various resins, adhesives and inks) directly and indirectly affect both the purchase price of the raw materials and market demand for its product offerings. The Company diligently monitors raw materials and commodities pricing across all its product lines in an effort to preserve margins.

Selling, General and Administrative Expenses

Selling, general and administrative expenses increased $2,174,000 or 18% to $13,969,000 for the quarter ended May 31, 2021 compared to $11,795,000 in the prior year quarter. Selling, general and administrative expenses increased $1,535,000 or 4% to $38,560,000 in the fiscal year-to-date period compared to $37,025,000 in the same period in fiscal 2020. As a percentage of revenue, selling, general and administrative expenses represented 18% for both the current year third quarter and fiscal year-to-date period, compared to 18% and 19% for the three- and nine-month periods of the prior year, respectively.

Table of Contents

Research and Product Development Costs

Research and Product Development Costs decreased $1,000 or less than one percent to $957,000 during the third quarter of fiscal 2021, compared to $958,000 in fiscal 2020. Research and Product Development Costs decreased $11,000 or less than one percent to $3,034,000 during the first nine months of fiscal 2021, compared to $3,045,000 in the same period of fiscal 2020. Research and development stayed relatively consistent from fiscal 2020 to 2021 as the Company continued focused development work on strategic product lines.

Operations Optimization Costs

During the second quarter of fiscal 2021, Chase began moving the sealant systems operations, part of the Adhesives, Sealants and Additives segment’s electronic and industrial coatings product line, from its Newark, CA location to its Hickory, NC facility. This is in line with the Company’s ongoing initiative to consolidate its manufacturing plants and streamline its existing processes. The sealant systems operations and Newark, CA location came to Chase Corporation as part of the fiscal 2017 acquisition of the operations of Resin Designs, and the Company’s lease there will terminate in the current fiscal year. The Company recognized $22,000 and $120,000 in expense related to the move in the three-month and nine-month periods ended May 31, 2021.

During the first quarter of fiscal 2020 (prior year), the Company commissioned third party led studies regarding the potential upgrading of the Company’s current worldwide ERP system. Chase is currently reviewing the data and recommendations provided by the study and may further utilize third-party engineering, IT and other professional services firms in the future for similar work, as well as work around the Company’s facilities rationalization and consolidation initiative. The Company recognized $150,000 in expense related to these services in the first half of fiscal 2020. Given the ongoing nature of the review, an estimate of future costs, including costs that could be capitalized, cannot currently be determined.

During the third quarter of fiscal 2019, Chase began moving the pulling and detection operations from its Granite Falls, NC location to its Hickory, NC facility. This is in line with the Company’s ongoing initiative to consolidate its manufacturing plants and streamline its existing processes. At the time, the pulling and detection operations were the only Chase-owned production operations in Granite Falls, NC, with the remaining portions of the building being either utilized for research and development or leased to a third party. The process of moving, including moving internal research and development capabilities, was substantially completed during the second quarter of fiscal 2020 (prior year). The Company recognized $559,000 in expense related to the move in the nine-month period ended May 31, 2020, having recognized $526,000 in expense during the second half of fiscal 2019. This project is substantively completed, and no costs were recorded in the first nine months of fiscal 2021, and any future costs related to this move are not anticipated to be significant to the condensed consolidated financial statements.

Table of Contents

On June 25, 2018, the Company announced to its employees the planned closing of its Pawtucket, RI manufacturing facility effective August 31, 2018. This is in line with the Company’s ongoing efforts to consolidate its manufacturing plants and streamline its existing processes. The manufacture of products previously produced in the Pawtucket, RI facility was substantially moved to Company facilities in Oxford, MA and Lenoir, NC during a two-month transition period. The Company completed the sale of its Pawtucket, RI location to a third-party in April 2020, for net proceeds totaling $1,810,000. This transaction resulted in a gain of $760,000 which was recorded during the third quarter of fiscal 2020. Also, during the third quarter of fiscal 2020, the Company recognized $85,000 in final Pawtucket, RI transition and exit costs, with no further costs related to this initiative anticipated in future periods.

Acquisition-Related Costs

In the second quarter of fiscal 2021, the Company incurred $128,000 of costs related to our February 5, 2021 acquisition of Emerging Technologies, Inc (“ETi”). This acquisition was accounted for as a business combination in accordance with applicable accounting standards, and all related professional service fees (including legal, accounting and actuarial fees) were expensed as incurred within the second fiscal quarter of 2021.

In the three- and nine-month periods ended May 31, 2020, the Company incurred $20,000 and $153,000 of costs related to our September 1, 2020 acquisition of ABchimie, respectively. This acquisition was accounted for as a business combination in accordance with applicable accounting standards, and all related professional service fees (including banking, legal, accounting and actuarial fees) were expensed as incurred within the second, third and fourth quarters of fiscal 2020 (total of $274,000 in acquisition-related expense recognized over the last three quarters of fiscal 2020). The transaction was consummated at the beginning of fiscal 2021.

Gain on Sale of Real Estate

In April 2020, the Company finalized the sale of its Pawtucket, RI location for net proceeds of $1,810,000. This transaction resulted in a gain of $760,000 which was recorded during the quarter ended May 31, 2020.

Loss (Gain) on Contingent Consideration

As a component of the September 1, 2020 acquisition of ABchimie, the Company incurred a performance-based earn out liability potentially worth an additional €7,000,000 (approximately $8,330,000 at the time of the transaction) in consideration. Following its initial recording at the acquisition date, $262,000 and $995,000 in expense related to adjustments to the performance-based earn out accrual were recorded for the three and nine months ended May 31, 2021, respectively.

Interest Expense

Interest expense increased $1,000 or 1% to $68,000 for the quarter ended May 31, 2021 compared to $67,000 in the prior year third quarter. Interest expense increased $26,000 or 15% to $204,000 for the first nine months of fiscal 2021 compared to $178,000 in the prior year period. As the Company had no outstanding balance on its revolving debt facility for both periods, interest expense has remained relatively low.

Other Income (Expense)

Other income (expense) was an expense of $260,000 in the quarter ended May 31, 2021, compared to an expense of $307,000 in the same period in the prior year, a decrease of $47,000. Other income (expense) was an expense of $758,000 in the nine months ended May 31, 2021, compared to an expense of $1,096,000 in the comparable period in the prior year, a decrease of $338,000. Other income (expense) primarily includes foreign exchange gains (losses) caused by changes in exchange rates on transactions or balances denominated in currencies other than the functional currency of the Company’s subsidiaries, non-service cost components of periodic pension expense (including pension-related settlement costs due to the timing of lump-sum distributions), interest income, rental income and other receipts that are not classified as trade, royalties or commissions.

Table of Contents

Income Taxes

The effective tax rate for the quarter ended May 31, 2021 was 19.5%, compared to 20.9% for the quarter ended May 31, 2020. The effective tax rate for the nine months ended May 31, 2021 was 23.1%, compared to 24.7% for the nine months ended May 31, 2020.

Net Income

Net income increased $4,381,000 or 44% to $14,289,000 in the quarter ended May 31, 2021 compared to $9,908,000 in the prior year third quarter. Net income increased $9,148,000 or 36% to $34,297,000 in the nine months ended May 31, 2021 compared to $25,149,000 in the same period in the prior year. The increase in net income in both the third fiscal quarter and year-to-date period was primarily due to higher sales and an improved relative gross margin.

Table of Contents

Liquidity and Sources of Capital

The Company’s overall cash and cash equivalents balance increased $3,879,000 to $102,947,000 at May 31, 2021, from $99,068,000 at August 31, 2020. The increased cash balance is primarily attributable to cash provided by operations of $43,000,000, net of $22,241,000 utilized to acquire ABchimie on September 1, 2020, $8,997,000 in cash utilized to acquire the operations of Emerging Technologies, Inc. (“ETi”) on February 5, 2021 and the $7,557,000 dividend paid in December 2020. Of the above-noted balances, $27,023,000 and $42,615,000 were held outside the United States by Chase Corporation and its foreign subsidiaries as of May 31, 2021 and August 31, 2020, respectively. Given the Company’s cash position and borrowing capability in the United States and the potential for increased investment and acquisitions in foreign jurisdictions (as evidenced by the recent acquisition of ABchimie in France), prior to the second quarter of fiscal 2018 the Company did not have a history of repatriating a significant portion of its foreign cash. With the passage of the Tax Cuts and Jobs Act (the “Tax Act”) in the second fiscal quarter of 2018, significant changes in the Internal Revenue Code were enacted, changing the U.S. taxable nature of previously unrepatriated foreign earnings. Following the passage of the Tax Act, the Company repatriated $10,499,000 in U.K. foreign earnings in fiscal 2018 and $17,230,000 in fiscal 2019. No additional amounts were repatriated in fiscal year 2020 or the first nine months of fiscal 2021. Please see Note 14 — “Income Taxes” to the Condensed Consolidated Financial Statements for further discussion of the effects of the Tax Act.

Cash flow provided by operations was $43,000,000 in the first nine months of fiscal year 2021 compared to $42,665,000 in the same period in the prior year. Cash provided by operations during the current period was primarily related to operating income. Negatively impacting the cash flow from operations was an increase in accounts receivable, on higher sales in the current year third quarter, partially offset by a decrease in the volume of inventory on hand and a rise in accounts payable.

The ratio of current assets to current liabilities was 7.2 as of May 31, 2021 compared to 7.7 as of August 31, 2020. The ratio decreased over the first nine months of fiscal 2021 primarily due to increases accounts payable at May 31, 2021.

Cash flow used in investing activities of $33,106,000 was largely due to the cash on hand purchases of both ABchimie and ETi and cash spent on capital purchases of machinery and equipment in fiscal 2021.

Cash flow used in financing activities of $7,842,000 was primarily related to payments of our annual dividend in December 2020 and taxes on restricted stock vested in fiscal 2021.

On November 12, 2020, Chase Corporation announced a cash dividend of $0.80 per share (totaling $7,557,000). The dividend was paid on December 7, 2020 (the second quarter of fiscal 2021) to shareholders of record on November 27, 2020.

On December 15, 2016, the Company entered an Amended and Restated Credit Agreement (the “Credit Agreement”) with Bank of America, acting as administrative agent, and with participation from Citizens Bank and JPMorgan Chase Bank (collectively with Bank of America, the “Lenders”). The Credit Agreement is an all-revolving credit facility with a borrowing capacity of $150,000,000, which can be increased by an additional $50,000,000 at the request of the Company and the individual or collective option of any of the Lenders. The facility matures December 15, 2021 (second quarter of fiscal 2022). The Credit Agreement contains customary affirmative and negative covenants that, among other things, restrict the ability to incur additional indebtedness and require lender approval for acquisitions by the Company and its subsidiaries over a certain size. It also requires the Company to maintain certain financial ratios, including a consolidated net leverage ratio (as defined in the facility) of no more than 3.25 to 1.00, and a consolidated fixed charge coverage ratio (as defined in the facility) of at least 1.25 to 1.00. The Company was compliant with the debt covenants as of May 31, 2021. The applicable interest rate for the Credit Agreement is based on the effective LIBOR plus an additional amount in the range of 1.00% to 1.75%, depending on the consolidated net leverage ratio or, at the Company’s option, at the bank’s base lending rate. At May 31, 2021, there was no outstanding principal balance, and as such no applicable interest rate. The Company expects to renew this facility, or enter into a new facility, prior to the current facility’s expiration to maintain Chase’s ability to support its strategic initiatives.

Table of Contents

The Company has several ongoing capital projects, as well as its facility rationalization and consolidation initiative, which are important to its long-term strategic goals. Machinery and equipment may be added as needed to increase capacity or enhance operating efficiencies in the Company’s production facilities.

The Company may acquire companies or other assets in future periods which are complementary to the existing business. The acquisition of ABchimie included a potential earnout based on performance of up to an additional €7,000,000 (approximately $8,330,000 at the time of the transaction), which the Company expects to pay with cash on hand if the applicable conditions are met. The acquisition of ETi includes a $1,000,000 withholding, which is payable by the Company within eighteen months of the acquisition. The Company believes that its existing resources, including cash on hand and the Credit Agreement, together with cash generated from operations and additional bank borrowings, will be sufficient to fund its cash flow requirements through at least the next twelve months. However, there can be no assurance that additional financing, if needed, will be available on favorable terms, if at all.

To the extent that interest rates increase in future periods, the Company will assess the impact of these higher interest rates on the financial and cash flow projections of its potential acquisitions.

The Company has no significant off-balance sheet arrangements.

Table of Contents

Contractual Obligations

Please refer to Item 7 “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in the Company’s Annual Report on Form 10-K for the fiscal year ended August 31, 2020 for a complete discussion of its contractual obligations.

Recent Accounting Standards

Please see Note 2 — “Recent Accounting Standards” to the Condensed Consolidated Financial Statements for a discussion of the effects of recently issued and recently adopted accounting pronouncements.

Critical Accounting Policies

Chase Corporation’s financial statements are prepared in accordance with accounting principles generally accepted in the United States. To apply these principles, the Company must make estimates and judgments that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosure of contingent assets and liabilities. In many instances, the Company reasonably could have used different accounting estimates and, in other instances, changes in the accounting estimates are reasonably likely to occur from period to period. Accordingly, actual results could differ significantly from the Company’s estimates. To the extent that there are material differences between these estimates and actual results, the Company’s financial condition or results of operations will be affected. The Company bases its estimates and judgments on historical experience and other assumptions that it believes to be reasonable at the time and under the circumstances, and it evaluates these estimates and judgments on an ongoing basis. The Company refers to accounting estimates and judgments of this type as critical accounting policies, judgments, and estimates. Other than changes which came as a result of adopting ASU No. 2016-13, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,” which is discussed within Note 2 — “Recent Accounting Standards” of the Condensed Consolidated Financial Statements contained herein, management believes that there have been no material changes during the nine months ended May 31, 2021 to the critical accounting policies reported in Item 7 “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the fiscal year ended August 31, 2020.

Table of Contents

Item 3 — Quantitative and Qualitative Disclosures about Market Risk

Chase Corporation limits the amount of credit exposure to any one issuer. At May 31, 2021, other than the Company’s restricted investments (which are restricted for use in non-qualified retirement savings plans for certain key employees and members of the Board of Directors), all of its funds were either in demand deposit accounts or investment instruments that meet high credit quality standards, such as money market funds, government securities, or commercial paper.

Chase Corporation’s U.S. operations have limited currency exposure since substantially all transactions are denominated in U.S. dollars. However, the Company’s European and Asian operations are subject to currency exchange fluctuations. The Company continues to review its policies and procedures to control this exposure while maintaining the benefit from these operations and sales not denominated in U.S. dollars. The effect of an immediate hypothetical 10% change in the exchange rate between the British pound and the U.S. dollar would not have a material direct effect on the Company’s overall liquidity. As of May 31, 2021, the Company had cash balances in the following foreign currencies (with USD equivalents, dollars in thousands):


Currency Code	Currency Name	USD Equivalent at May 31, 2021
GBP	British Pound	$	13,465
EUR	Euro	$	6,236
CAD	Canadian Dollar	$	1,810
CNY	Chinese Yuan	$	666
INR	Indian Rupee	$	528

The Company will continue to review its current cash balances denominated in foreign currency considering current tax guidelines, including the impact of the Tax Act to the U.S. Internal Revenue Code, working capital requirements, infrastructure improvements and potential acquisitions.

The Company recognized a foreign currency translation gain for the nine months ended May 31, 2021 in the amount of $3,273,000 related to Chase Corporation’s European and Indian operations, which is recorded in other comprehensive income (loss) within its Statement of Equity and Statement of Comprehensive Income. The Company does not have or utilize any derivative financial instruments.

The Company pays interest on its outstanding long-term debt at interest rates that fluctuate based upon changes in various base interest rates. There was no outstanding balance of long-term debt on May 31, 2021. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Liquidity and Sources of Capital,” together with Note 12 — “Fair Value Measurements” and Note 16 — “Long-Term Debt” to the Condensed Consolidated Financial Statements for additional information regarding the Company’s outstanding long-term debt. An immediate hypothetical 10% change in variable interest rates would not have a material direct effect on the Company’s Condensed Consolidated Financial Statements.

Table of Contents

Item 4 — Controls and Procedures

Evaluation of disclosure controls and procedures

The Company maintains disclosure controls and procedures that are designed to ensure that information required to be disclosed in Chase Corporation’s reports under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and that such information is accumulated and communicated to its management, including its Chief Executive Officer and Chief Financial Officer, as appropriate, to allow for timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

The Company carries out a variety of ongoing procedures under the supervision and with the participation of its management, including its Chief Executive Officer and Chief Financial Officer, to evaluate the effectiveness of the design and operation of its disclosure controls and procedures. Based on the foregoing, the Company’s Chief Executive Officer and Chief Financial Officer concluded that its disclosure controls and procedures were effective at a reasonable assurance level as of the end of the period covered by this report.

Changes in internal control over financial reporting

During the quarter ended May 31, 2021, the Company continued the process of implementing financial internal controls on the operations associated with ABchimie, acquired in September 2020, and Emerging Technologies, Inc. (ETi), acquired in February 2021.

Other than the foregoing, there have not been any changes in the Company’s internal control over financial reporting during the quarter ended May 31, 2021 that have materially affected, or are reasonably likely to materially affect, its internal control over financial reporting.

Table of Contents

Part II — OTHER INFORMATION

Item 1 — Legal Proceedings

The Company is involved from time to time in litigation incidental to the conduct of its business. Although the Company does not expect that the outcome in any of these matters, individually or collectively, will have a material adverse effect on its financial condition, results of operations or cash flows, litigation is inherently unpredictable. Therefore, judgments could be rendered, or settlements agreed to, that could adversely affect the Company’s operating results or cash flows in a particular period. The Company routinely assesses all its litigation and threatened litigation as to the probability of ultimately incurring a liability and records its best estimate of the ultimate loss in situations where it assesses the likelihood of loss as probable.

Item 1A — Risk Factors

Please refer to Item 1A in our Annual Report on Form 10-K for the fiscal year ended August 31, 2020 for a complete discussion of the risk factors which could materially affect our business, financial condition or future results.

Item 6 — Exhibits


Exhibit Number		Description
31.1		Certification of principal executive officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2		Certification of principal financial officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1		Certification of principal executive officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*
32.2		Certification of principal financial officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*
10.1		Severance Agreement between the Company and Michael J. Bourque, dated January 27, 2021**
10.3.3		Second Amendment to the Chase Corporation Employees’ Supplemental Savings Plan, dated April 6, 2021**
101		The following materials from this Quarterly Report on Form 10-Q, formatted in Inline Extensible Business Reporting Language (iXBRL): (i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statements of Operations, (iii) Condensed Consolidated Statements of Comprehensive Income, (iv) Condensed Consolidated Statement of Stockholders’ Equity, (v) Condensed Consolidated Statements of Cash Flows, and (vi) Notes to Unaudited Condensed Consolidated Financial Statements.
104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

*Furnished, not filed

**Identifies management plan or compensatory plan or arrangement.

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


	Chase Corporation


Dated: July 12, 2021	By:	/s/ Adam P. Chase
		Adam P. Chase
		President and Chief Executive Officer


Dated: July 12, 2021	By:	/s/ Michael J. Bourque
		Michael J. Bourque
		Treasurer and Chief Financial Officer

Exhibit 10.1

SEVERANCE AGREEMENT

This Agreement dated as of January 27, 2021 is by and between Chase Corporation, a Massachusetts corporation (the “Company”), and Michael Bourque, (the “Executive”).

WHEREAS, the Company and the Executive desire to enter into a Severance Agreement as set forth below (the “Agreement”).

NOW, THEREFORE, the Company and the Executive hereby agree as follows:

Definitions. For purposes of this Agreement only, the following definitions shall apply:

(a)

“Cause” means the occurrence of any of the following events:

(i) the Executive’s willful and continued failure to substantially perform his duties to the Company (other than any such failure resulting from the Employee’s incapacity due to Disability), provided that the Company has delivered a written demand of substantial performance to the Executive specifically identifying the manner in which the Company believes that the Executive has not substantially performed his duties and that the Executive has not cured such failure within ten (10) days after such demand or such longer period of time as may be provided by the Board in writing;

(ii) willful conduct by the Executive which is demonstrably and materially injurious to the Company;

(iii) material violation of any Company policy, including any code of conduct or standard of ethics of the Company applicable to the Executive;

(iv) the commission of any fraud, embezzlement, misappropriation or breach of fiduciary duty by the Executive relating to the performance of the Executive’s services to the Company;

(v) the Executive’s conviction of, or pleading of guilty or nolo contendere to, a felony or any crime involving moral turpitude, dishonesty or theft; or

(vi) the Executive’s willful violation of any material provision of any confidentiality, nondisclosure, assignment of invention, noncompetition or similar agreement entered into by the Executive in connection with his employment by the Company.

(b)

“Change in Control” means the occurrence of any of the following events:

(i) any “person” (as such term is used in Sections 13(d) and 14(d) of the Exchange Act), other than the Company, any trustee or other fiduciary holding securities under an employee benefit plan of the Company or a corporation owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their ownership of stock of the Company becomes the “beneficial owner” (as defined in

Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of the Company representing 50% or more of the combined voting power of the Company’s then outstanding securities;

(ii) during any period of twelve (12) consecutive months (not including any period prior to the date of this Agreement), individuals who at the beginning of such period constitute the Board of Directors of the Company (the “Board”) and any new director (other than a director designated by a person who has entered into an agreement with the Company to effect a transaction described in subparagraphs (i), (ii) or (iii)) whose election by the Board or nomination for election by the Board or by the stockholders of the Company was approved by a vote of at least a majority of the directors then still in office who either were directors at the beginning of such period or whose election or nomination for election was previously so approved, cease for any reason to constitute a majority thereof;

(iii) the stockholders of the Company approve and the Company consummates a merger or consolidation of the Company with any other corporation, other than (i) a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) at least 50% of the combined voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation or (ii) a merger or consolidation effected to implement a recapitalization of the Company (or similar transaction) in which no “person” (as hereinabove defined) acquires 50% or more of the combined voting power of the Company’s then outstanding securities; or

(iv) the stockholders of the Company approve and the Company consummates a plan of complete liquidation of the Company or an agreement for the sale or disposition by the Company of all or substantially all of the Company’s assets.

(c)“Disability” means that the Executive has been adjudged to be disabled and qualified to receive payments under a group long-term disability plan maintained by the Company.

(d)“Good Reason” means the occurrence, in connection with a Change in Control, of any of the following events without the Executive’s prior written consent in an agreement expressly referencing this provision of this Agreement (provided that the Executive shall have given the Company prior written notice describing such event within 90 days of the initial existence of the condition(s) giving rise to the Good Reason and the matter shall not have been fully remedied by the Company within 30 days after receipt of such notice):

(i) any reduction of the Executive’s then existing annual base salary unless such reduction occurs simultaneously with a reduction in salaries applicable on a Company-wide basis in a generally uniform manner due to a material deterioration in the Company’s financial condition;

(ii) a greater than 10% reduction in the Executive’s then existing annual cash bonus opportunities or other short-term cash incentive opportunities;

(iii) a material diminution in the Executive’s authority, duties or responsibilities, or the assignment of additional duties that are materially inconsistent with the title or office held by the Executive prior to the Change in Control except as had been agreed to by the Executive in a transition or succession plan;

(iv) any other action or inaction that constitutes a material breach by the Company of this Agreement; and

(v) any failure by the Company to obtain the assumption of this Agreement by any successor or assign or the Company.

2.Change in Control. If, within twelve (12) months immediately following a Change in Control, the Executive’s employment is terminated by the Company without Cause or the Executive terminates his employment with the Company for Good Reason, the Executive shall be entitled to the benefits set forth in Section 3.

3.Severance Benefits. Subject to the Executive’s compliance with the terms of this Agreement upon termination of Executive’s employment for reasons described in Section 2 above, the Company shall pay or provide the Executive with the severance benefits described in clauses 3(a) through 3(d) below (collectively, the “Severance Benefits”):

(a)payment of an amount equal to one hundred percent (100%) of the Executive’s base salary, in substantially equal installments in accordance with the Company’s regular payroll practices, for a period of twelve (12) months, such amount to be paid at a rate equal, on an annualized basis, to the greater of his annual base salary in effect immediately prior to the Change in Control or his annual base salary in effect immediately prior to the termination of employment;

(b)payment of an amount equal to one hundred percent (100%) of the average of the annual cash bonuses paid to the Executive for the two (2) most recently completed fiscal years of the Company immediately preceding the date of the Executive’s termination of employment. If the termination of employment occurs after the close of a Company fiscal year but prior to payment of the bonus, the most recent bonus to be used for purposes of the foregoing calculation shall be the amount of the bonus as declared by the Board, or if no such declaration has yet to be made then the most recent bonus shall be the amount of the target bonus previously established for the Executive for the then-completed fiscal year. Such amount shall be paid in substantially equal installments in accordance with the Company’s regular payroll practices for a period of twelve (12) months;

(c)continued participation in the benefits in effect for Executive as of the date of termination of employment, subject to the terms and conditions of the respective plans and applicable law, for a period of twelve (12) months following the termination date; provided that to the extent that the Company’s plans, programs and arrangements do not permit such continuation of Executive’s participation following his termination of employment, the Company shall provide the Executive with an amount which is sufficient for him to purchase equivalent benefits, such amount to be paid quarterly in advance; provided, further, however, that if the Executive becomes employed by another employer and is eligible to receive medical or other welfare benefits under another employer-provided plan, the Executive’s entitlement to participate in the Company’s

medical or other welfare benefit plans or to receive such alternate payments shall, to the extent such medical or welfare benefits are offered by the other employer, cease as of the date the Executive is eligible to participate in such plans, and the Executive shall notify the Company of his eligibility under such other plans; and

(d)reasonable costs of an outplacement service used by the Executive (up to $10,000 per full or partial calendar year) for a period not to exceed one year following termination of employment.

Subject to the timely execution and non-revocation of the Release described in Section 5 below, and the other terms and conditions of this Agreement (including Section 7 regarding restrictive covenants), the Severance Benefits described in this Section 3 shall commence to be paid and provided to the Executive with the first regular payroll period following the Executive’s termination date.

In addition to the Severance Benefits described above, and regardless of whether the Executive executes the Release, the Company shall (i) pay the Executive on his date of termination of employment any base salary that was earned but unpaid through the date of termination, (ii) pay the Executive any earned but unpaid vacation or other paid time-off in accordance with the Company’s policies and applicable laws, and (iii) pay or provide, as the case may be, any earned and vested employee benefits (including equity awards) in accordance with the terms of the governing documents for such plans, programs or arrangements.

Taxes.

(a)All Severance Benefits to be provided to the Executive under this Agreement will be subject to any required withholding of federal, state and local income and employment taxes.

(b)Notwithstanding anything in this Agreement to the contrary, if any of the Severance Benefits provided for in this Agreement together with any other payments and benefits which the Executive has the right to receive from the Company in connection with a change in control (the “Total Payments”) would constitute a “parachute payment” as defined in Section 280G(b)(2) of the Internal Revenue Code of 1986, as amended (the “Code”), the Executive shall receive the Total Payments unless (i) the after-tax amount that would be retained by the Executive (after taking into account all federal, state and local income taxes payable by the Executive and the amount of any excise taxes payable by the Executive under Section 4999 of the Code (the “Excise Taxes”)) if the Executive were to receive the Total Payments has a lesser aggregate value than (ii) the after-tax amount that would be retained by the Executive (after taking into account all federal, state and local income taxes payable by the Executive) if the Executive were to receive the Total Payments reduced to the largest amount as would result in no portion of the Total Payments being subject to the Excise Taxes (the “Reduced Payments”), in which case the Executive shall be entitled only to the Reduced Payments. If the Executive is to receive the Reduced Payments, the Company shall reduce the Parachute Amount by reducing or eliminating the Severance Benefits under this Agreement in the order in which they first appear in Section 4 and then by reducing or eliminating any acceleration of vesting of equity awards in each case by the least amount necessary.

(c)The parties to this Agreement intend that the Severance Benefits that may be provided under this Agreement shall be exempt from, or comply with, the requirements of Section 409A of the Code. Any Severance Benefits described in this Agreement that are due within the “short-term deferral period” as defined by Section 409A of the Code, or that qualify as “involuntary separation pay” within the meaning of the Section 409A regulations, shall not be treated as nonqualified deferred compensation unless applicable law requires otherwise. If any amount payable under this Agreement upon a termination of employment is determined by the Company to constitute nonqualified deferred compensation for purposes of Section 409 of the Code, such amount shall not be paid unless and until the Executive’s termination of employment is also a “separation from service” within the meaning of Section 409A of the Code. To the extent that the Executive is a “specified employee” for purposes of Section 409A of the Code, any payment that constitutes nonqualified deferred compensation under Section 409A of the Code will not commence until the first business day after the date that is six months following the Executive’s separation from service (the “Delayed Payment Date”). On the Delayed Payment Date the Company will pay to the Executive a lump sum equal to all amounts that would have been paid during the period of the delay if the delay were not required by Section 409A of the Code and any remaining payments shall be paid as scheduled. For purposes of this Agreement, each payment in a series of payments shall be regarded as a “separate payment” within the meaning of Section 409A of the Code.

5.Release. The Executive’s entitlement to receive the Severance Benefits contemplated by this Agreement hereof shall be contingent upon the Executive executing and not revoking a release and covenant not to sue in form and substance reasonably satisfactory to the Company (the “Release”) within 45 days after his termination of employment. If such 45 day period begins in one calendar year and ends in another calendar year, any payments that are nonqualified deferred compensation for purposes of Section 409A of the Code shall commence in the later calendar year with the first such installment including any amounts that would have been paid during the period of delay if the delay were not required by Section 409A. By execution of this Agreement, the Executive hereby acknowledges and agrees that such payments are and shall be good and sufficient consideration for such Release.

6.No Duty to Mitigate. In no event shall the Executive be obligated to seek other employment or take any other action by way of mitigation of the amounts payable to the Executive under any of the provisions of this Agreement and, except as contemplated by Section 3(b) hereof, any Severance Benefits payable to the Executive hereunder shall not be subject to reduction for any compensation received from other employment.

7.Restrictive Covenants. The Executive reaffirms the covenants set forth in the Confidentiality, Non-Competition, Non-Solicitation, Patents and Inventions Agreement that he entered into with the Company dated December 20, 2020 (the “Restrictive Covenant Agreement”) which are incorporated in this Agreement by reference as if such covenants were set forth herein. The Executive further agrees that payment of any amounts and the provision of any benefits under this Agreement are subject to continued compliance with the Restrictive Covenant Agreement.

8.Clawback. In addition to the provisions of Section 7 (Restrictive Covenants), the Severance Benefits under this Agreement are subject to clawback, recoupment, recovery and set-off in accordance with the written policies adopted by the Board from time to time for Company

officers generally for compliance with and enforcement of the requirements of the Sarbanes-Oxley Act of 2002, the Dodd-Frank Wall Street Reform and Consumer Protection Act and any other subsequently-enacted federal, state or local laws regarding clawback, recoupment, recovery or set-off of compensation and benefits.

9.Cooperation. The Executive agrees that following his termination of employment for any reason, he will cooperate fully with the Company in the defense or prosecution of any government investigations and any government or third-party claims or actions now in existence or which may be brought or threatened in the future against or on behalf of the Company, including any claims or actions against its directors, officers and employees, in which the Executive has personal knowledge of any relevant facts. The Executive’s cooperation in connection with such claims or actions shall include him being available, within reason given the constraints of personal commitments, future employment or job search activities, to assist with any audit, inspection, proceeding or other inquiry, and to act as a witness in connection with any litigation or other legal proceeding affecting the Company or its subsidiaries.

10.

Successors and Assigns.

(a)This Agreement is personal to the Executive and is not assignable by the Executive, other than by will or the laws of descent and distribution, without the prior written consent of the Company.

(b)This Agreement shall inure to the benefit of and be binding upon the Company and its successors and assigns.

(c)The Company will require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business and/or assets of the Company to assume expressly and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken place. As used in this Agreement, “Company” shall mean the Company as defined above and any successor to its business and/or assets that assumes and agrees to perform this Agreement.

11.No Right to Continued Employment. Nothing contained in this Agreement shall be considered a contract of employment or construed as giving the Executive any right to be retained in the employ of the Company. Nothing in this Agreement shall otherwise restrict in any way the rights of the Company to terminate the Executive at any time and for any reason, with or without cause.

12.Miscellaneous.

(a)Applicable Law. This Agreement shall be governed by and construed in accordance with the laws of the Commonwealth of Massachusetts, without giving effect to the conflict of laws principles thereof.

(b)Amendment; Waiver. This Agreement may not be modified or amended in any manner except by a written agreement executed by the parties hereto or their respective successors and legal representatives. The waiver by either party of compliance with any provision of this

Agreement by the other party shall not operate or be construed as waiver of any other provision of this Agreement, or of any subsequent breach by such party or a provision of this Agreement.

(c)Entire Understanding. This Agreement constitutes the entire understanding and agreement between the parties hereto with regard to the compensation and benefits payable to the Executive in the circumstances described herein, superseding all prior understandings and agreements, whether oral or written, excluding the Restrictive Covenant Agreement.

(d)Fees and Expenses. The Company agrees to pay as incurred and within 30 days after submission of supporting documentation, to the full extent permitted by law, all legal fees and related expenses the Executive may reasonably incur as a result of any contest (regardless of the outcome thereof) by the Company, the Executive or others of the validity or enforceability of, or liability under, any provision of this Agreement (including as a result of any contest by the Executive about the amount of any payment pursuant to this Agreement) following a Change in Control.

(e)Notices. All notices and other communications hereunder shall be in writing and shall be delivered by hand delivery, by a reputable overnight courier service, or by registered or certified mail, return receipt requested, postage prepaid, in each case addressed as follows:

If to the Company:

Chase Corporation

295 University Avenue

Westwood, MA 02090

Attention: General Counsel

If to the Executive:

Michael Bourque

at his last known residential address as set forth in the Company’s records,

or to such other address as either party shall have furnished to the other in writing in accordance herewith. Any notice or communication shall be deemed to be delivered upon the date of hand delivery, one day following delivery to an overnight courier service, or three days following mailing by registered or certified mail.

(f)Headings. The headings of paragraphs herein are included solely for convenience of reference and shall not control the meaning of interpretations of any of the provisions of this Agreement.

(g)Severability. The invalidity or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement, which shall remain in full force and effect.

(h)Counterparts. This Agreement may be executed in one or more counterparts, all of which shall be considered one and the same agreement, and each of which shall be deemed an original.

IN WITNESS WHEREOF, the Company has caused this Agreement to be executed by its duly authorized officer and the Executive has executed this Agreement as of the date first written above.

CHASE CORPORATION			Michael Bourque

By:

Exhibit 10.3.3

A Leading Manufacturer of Protective

Materials for High Reliability Applications

AMENDMENT NO. 2

CHASE CORPORATION

EMPLOYEES’ SUPPLEMENTAL SAVINGS PLAN

WHEREAS Chase Corporation (the “Company”) established and maintains the Chase Corporation Employees’ Supplemental Savings Plan, effective January 1, 1994, amended January 1, 2005, amendment December 21, 2016, and further amended, restated and effective July 9, 2020 (the “Plan”); and

WHEREAS, Article III establishes eligibility and participation in the plan;

WHEREAS, the Company desires to amend the Plan as set forth below, effective April 6, 2021.

NOW, THEREFORE, the Plan is hereby amended, in the following respects:

ARTICLE III

ELIGIBILITY

An employee shall be eligible to participate in the Plan if s/he has satisfied the eligibility requirements for participation under the Savings Plan as set forth by the Board then the Chief Executive Officer, subject to the control of the Board shall: (i) have the power to authorize participation in the Supplemental Savings Plan for employees with the title of Vice President and above; (ii) select the plan administrator (iii) and perform such other duties and may exercise such other powers as it generally pertains to administration of the plan as determined by the Board from time to time.

Except as amended above the terms of the Plan remain in full force and effect.

295 University Ave., Westwood, MA 02090 781-332-0700 Fax 781-332-0701 www.chasecorp.com

CHASE CORPORATION: GLOBAL OPERATIONS CENTER

IN WITNESS WHEREOF, this Amendment No. 2 is executed this 6^th day of April 2021 to be effective as of the date first written above.

CHASE CORPORATION

Jeffery D. Haigh, Corporate Secretary

295 University Ave., Westwood, MA 02090 781-332-0700 Fax 781-332-0701 www.chasecorp.com

CHASE CORPORATION: GLOBAL OPERATIONS CENTER

Exhibit 31.1

CERTIFICATION

I, Adam P. Chase, certify that:

I have reviewed this Quarterly Report on Form 10-Q of Chase Corporation;

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: July 12, 2021


	/s/ Adam P. Chase

	Adam P. Chase
	President and Chief Executive Officer
	(Principal executive officer)

Exhibit 31.2

CERTIFICATION

I, Michael J. Bourque, certify that:

I have reviewed this Quarterly Report on Form 10-Q of Chase Corporation;

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: July 12, 2021


	/s/ Michael J. Bourque

	Michael J. Bourque
	Treasurer and Chief Financial Officer
	(Principal financial officer)

Exhibit 32.1

CERTIFICATION

PURSUANT TO

18 U.S.C. 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned officer of Chase Corporation (the “Company”) hereby certifies that the Company’s Quarterly Report on Form 10-Q for the period ended May 31, 2021 (the “Report”), as filed with the Securities and Exchange Commission on the date hereof, fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended, and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. This certificate is furnished solely pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

Date: July 12, 2021


/s/ Adam P. Chase

Adam P. Chase
President and Chief Executive Officer
(Principal executive officer)

Exhibit 32.2

CERTIFICATION

PURSUANT TO

18 U.S.C. 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Date: July 12, 2021


/s/ Michael J. Bourque

Michael J. Bourque
Treasurer and Chief Financial Officer
(Principal financial officer)